Vaccine Trust Survey report Methodology and Key Results Read more: www.thevaccinetrustproject.com
I N T R O D U C I N G
T H E
T R U S T
M O D E L
This work set out to build a tool to better understand, measure, and enable targeted trust-building efforts in a health-seeking context—critical for building demand for health services
“Trust is an area where governments can move the needle, and the fact that it outweighs traditional measures of healthcare capacity and pandemic preparedness should be a wakeup call for all of us” Thomas J. Bollyky, director of the CFR global health programme & author of a recent Lancet study showing a link between trust and COVID-19 vaccination rates
Situation: trust as a critical – but poorly understood demand driver Trust is increasingly in-focus as a critical component in efficiently health-seeking behavior – but it is also clear that there is no consensus on how to understand trust today
Ambition: a trust-building a survey tool for decision-makers The ambition of this work is to develop a tool capable of helping decision-makers (e.g. NGO’s, governments, funders, and donors) harness the power of trust-based health interventions – ultimately driving efficient vaccine uptake through increased demand 2
I N T R O D U C T I O N
O F
T H E
T R U S T
F R A M E W O R K
T RU S T I N T H E …
Recap: The ethnographic research led to a trust model with four types of trust can be understood in isolation and through their relationships with each other—we call these quadrants and the relationships between them The Vaccine Trust Framework
Health system promise
Vaccine promise
Does the health system have my and my community’s best interests at heart?
Do I believe that this vaccine has value for me and my community?
A U T O N O M Y F A I R N E S S P R I O R I T Y
In isolation, each quadrant can help explain vaccine uptake, and identify where to target trust-building efforts to ensure vaccine uptake…
… and combined, the four trust types form a holistic understanding of trust that can more robustly help predict and understand vaccine behavior
Zooming in one type of trust in isolation can provide deep understanding of the barriers to vaccine uptake and where to target trust efforts.
Looking at the four trust quadrants combined provides a robust understanding of trust that can help predict vaccine uptake – and shed light on the quadrants' interaction
B E N E F I T A L I G N M E N T
A C C E S S
R E L E VA N C E S A F E T Y
Healthcare delivery
Vaccine delivery
Does the health system generally work for me and my community?
Do I feel this vaccine is available and accessible to me and my community?
C A P A B I L I T Y A F F O R D A B I L I T Y C O M P E T E N C E
A D E Q U A C Y
O F
C O M P A S S I O N
D E L I V E RY
S E T T I N G
I N F O
C O N F I D E N T I A L I T Y
A G E N C Y
3
I N T R O D U C T I O N
O F
T H E
T R U S T
F R A M E W O R K
Each trust types consists of multiple trust dimensions Health system promise
Vaccine promise
The perception that the health system recognizes people’s autonomy in making decisions about their own health
AU TO N O M Y
The perceived value of the vaccine to child and community
B E N E F I T The perception that the health system provides services in a non-discriminatory manner
FA I R N E S S
P R I O R I T Y
A L I G N M E N T
The perception that the health system works towards the same kinds of health outcomes as people The health system’s perceived ability to deliver on people’s expectations of treatment of issues that fall within the purview of the system
C A PA B I L I T Y
The perceived relevance of being protected against disease for child and community
R E L E VA N C E
The perceived risk of side effects or other adverse events
S A F E T Y
Healthcare delivery AC C E S S
The perceived ease of accessing healthcare – incl. distance, time, navigation, language barriers, and availability of medical provisions
A F F O R DA B I L I T Y
The perceived ability to get healthcare when needed without having to forego or delay treatment due to cost
C O M P E T E N C E
The perception that healthcare providers have the knowledge and skills required to attend to people’s issues
C O M PA S S I O N
The perception that providers engage patients with respect and recognition, and demonstrate a commitment to their betterment
C O N F I D E N T I A L I T Y
The perception that medical and personal information will be kept private and undisclosed outside the provider/patient relationship
Vaccine delivery A D E QUAC Y
O F
I N F O
The perceived completeness of the information provided about the vaccine
D E L I V E RY
S E T T I N G
The percieved appropriateness of the site(s) where the vaccine is delivered, including medical competence and safety when accessing the vaccine
AG E N C Y
The percieved adequacy of consent collection, including whether people trust they will be asked for their consent and whether their decision will be respected
4
I N T R O D U C T I O N
O F
T H E
T R U S T
F R A M E W O R K
The Vaccine Trust Framework offers a picture of the trust landscape at a specific time—over time, it gives insights into the dynamic interactions among the four trust quadrants EXAMPLE:
MANDATED
YEAR 1 Health system promise
Healthcare delivery
VACCINES
YEAR 3
Vaccine promise
Vaccine delivery
A vaccine is pushed through despite low vaccine trust e.g., by mandate…
Health system promise
Healthcare delivery
YEAR 5
Vaccine promise
Vaccine delivery
… which decreases the trust in the health system over time…
Health system promise
Healthcare delivery
Vaccine promise
Vaccine delivery
… creating even lower trust levels for future vaccines
This is a key component of the Vaccine Trust Framework within low-trust contexts:
Every intervention has a trust impact – positive or negative – which eventually impacts trust in the overall health system 5
I N T R O D U C T I O N
|
R E P O R T
O V E R V I E W
This report outlines the methodological choices behind the Vaccine Trust Framework and presents the key findings on trust and vaccine uptake in Kenya and Pakistan Chapters Methodology
Sample composition
Quantifying the framework
Differences in trust
Trust and the effect on vaccine uptake
HPV learnings
METHODOLOGY
SAMPLE COMPOSISTION
QUANTIFYING THE FRAMEWORK
DIFFERENCES IN TRUST
HPV LEARNINGS
• Summary statistics on key demographic and socioeconomic variables
• Calculate and present trust scores for Kenya and Pakistan
• Explore differences and in trust across key demographic and socioeconomic variables
TRUST AND THE EFFECT ON VACCINE UPTAKE
•
•
Operationalization of the Trust Framework Sampling strategy
• Key statistics on health seeking behaviors incl. vaccine rates
• Internal and external validation of the Vaccine Trust Framework
• Present the effect of trust on vaccine uptake • Explore how different trust types interact with each other • Explore the effect of trust on vaccines across genders and marginalized groups
• Present key learnings om HPV vaccine perceptions and key influencers in Kenya • Present preliminary findings on HPV and HPV vaccine awareness in Pakistan
6
Methodology Sample composition Quantifying the Trust Framework Differences in trust Trust and the effect on vaccine uptake HPV learnings 7
C H A P T E R
O V E R V I E W
In the following chapter, we outline the methodological choices behind the Vaccine Trust Framework and the survey strategy S U M M A RY
CHAPTER OUTLINE
Challenges with existing trust measurements We outline challenges with existing trust measures and how the Vaccine Trust Framework seek to improve these challenges
Operationalization
We walk through the process of operationalizing the survey, crafting the questions and outline key definitions
Testing and validating the survey tool
Sampling strategy and data processing
We lay forward how the survey tool itself was tested and validated to ensure high data quality
We present the sampling strategy and why we report on non-weighted data
The operationalization of the Vaccine Trust Framework is based on an extensive literature review and two rounds of ethnographic research in Kenya and Pakistan. The survey was reviewed by experts and tested extensively before going to the field. The survey strategically oversamples caregivers to girls aged 10-14 across Kenya and Pakistan. The results are unweighted. 8
M E T H O D O L O G Y
|
T R U S T
L I T E R AT U R E
Recap | Our review of the trust literature revealed four major challenges with approaches to measuring trust in a health system and vaccine context CHALLENGES
Trust measures are situational and imprecise
There is a lack of agreement on what trust is
Most trust measures are Western-centric
Trust measures are removed from decision-making
Existing trust measures are developed in an ad hoc manner and are rarely grounded in a deep, contextual understanding of trust
There is disagreement within the quantitative trust literature on what trust is, which dimensions are important, and how to measure them
Existing trust measures are developed and validated in a Western context with insufficient attention to potential LMIC specificities
Existing trust measures devote little attention to solutions and decisionsmakers’ perspectives and are rarely applied outside of academia
“More work should also be done to improve existing trust measures. Validity of the measures could be strengthened by using qualitative methods and pilot-testing scales and indices.” 1
“People's trust in the health system plays a role in explaining one’s adherence, access to and utilization of medical care [...]. Yet it is not easy to find trust measures and understand what they are measuring.” 2
“While we found growing numbers of health systems trust measures, very few were developed and validated in lowand middle-income countries.” 3
“Improving well-being requires solid evidence that can inform policymakers and citizens where, when, and for whom life is getting better… Nevertheless, certain topics have not yet received the attention […]Trust is one of these topics.” 4
1) Ozawa, Sachiko, and Pooja Sripad. "How do you measure trust in the health system? A systematic review of the literature." Social science & medicine 91 (2013): 10-14. 2) *How do you measure trust in the health system? A systematic review of the literature. Ozawa & Sripad. Soc Sci Med. August 2013
3) Ozawa, Sachiko, and Pooja Sripad. "How do you measure trust in the health system? A systematic review of the literature." Social science & medicine 91 (2013): 10-14. 4) OECD Guidelines on Measuring Trust. OECD. 2017
9
M E T H O D O L O G Y
|
T R U S T
L I T E R AT U R E
Recap | The Vaccine Trust Framework survey seek to improve each of these to deliver a data tool that is optimized for decision makers in LMIC contexts CHALLENGES
Trust measures are situational and imprecise
There is a lack of agreement on what trust is
Most trust measures are Western-centric
Trust measures are removed from decision-making
SOLUTIONS • The survey has been developed based on two rounds of detailed qualitative research
• Health- and vaccine-related trust have been operationalized meticulously
• The survey has undergone both
to capture their multiple dimensions and optimize measurement validity
ensure that it’s fit-for-purpose and that central concepts are understood • The survey integrates trust and vaccine measures to bring the two fields together
• Existing validated items from the literature have been used
expert review, cognitive testing, and pilot testing to
to the extent possible to further advance the field
• The survey has first and foremost been developed and validated for use in LMIC contexts, which have particular dynamics that aren’t captured by Westerncentric measures • The survey enables testing of hypotheses linking trust to vaccine acceptance in LMIC
contexts – and identification of relevant proxies for situations where a particular vaccine hasn’t been introduced yet
• Key decision makers both globally and nationally have been engaged from the outset
of the work to design a relevant data tool for their use cases • Data has been collected to not
only map trust nationally but also regionally, with an aim to
inform targeted approaches and vaccines to drive trust and vaccine uptake
10
M E T H O D O L O G Y
|
O P E R AT I O N A L I Z AT I O N
Operationalization
Expansion
HEALTH SYSTEM
VACCINES
DIMENSION #1
SUB-DIMENSION #1 Items SUB-DIMENSION #...
HPV COVID-19
Combining the insights from the C19 and HPV work has revealed imperatives for measuring trust validly EXAMPLE
INSIGHT
Access to healthcare is more than just distance to a clinic – it’s about knowing where to go in the first place, understanding the language and not having to wait for hours
PROCESS
PROMISE
Through ethnographic fieldwork in Kenya and Pakistan, the Vaccine Trust Framework has been operationalized and expanded to an additional vaccine; the HPV vaccine
S U RV E Y I M P L I C A T I O N
Measure trust in various sub-dimensions of access Operationalization has entailed defining the dimensions of each quadrant in a data-driven way and specifying valid indicators to measures them
Expansion has entailed shifting the focus from C19 to HPV vaccination to understand its trust dynamics and qualify the Trust Framework
The questions on access includes distance to clinic, langugae barriers, wait time and overall difficulty of accessing healthcare and was validated during the cognitive testing and pilot test.
11
M E T H O D O L O G Y
|
O P E R AT I O N A L I Z AT I O N
Systematically working from the C19 & HPV research and literature in the field enabled identification of the dimensions that constitute trust in each quadrant of the framework C19
RE SE ARCH
HPV
RESE ARCH
LIT
REVIEW
T RU S T
DIMENSIONS
12
M E T H O D O L O G Y
|
O P E R AT I O N A L I Z AT I O N
The trust quadrants and dimensions proceeded by breaking dimensions into sub-dimensions and finally survey items to measure them From quadrants to dimensions and sub-dimensions…
… measured through sets of items
50
items to measure the quadrants Trust Measurement Package Documents literature review
Where possible, validated items from the literature were used to build on best practice, enable comparisons, and contribute to cumulative knowledge. However, because of the granularity of the trust framework, a range of new items also had to be created and tested.
+75
items capturing, e.g., demographics, family composition, and vaccine behaviors were also added to fulfil the secondary aims 13
M E T H O D O L O G Y
|
O P E R AT I O N A L I Z AT I O N
Beyond trust items, a secondary aim was to gauge opinions on the HPV vaccine – and the questions was developed based on qualitative findings and existing HPV survey items EXAMPLE
OF
HPV
QUESTIONS
Examples of HPV specific questions
Please tell me if you do not at all agree, somewhat agree, or strongly agree: “Vaccines that are specifically made for adolescent girls are suspicious”
Please tell me if you do not at all agree, somewhat agree, or strongly agree: “I am concerned about serious side effects of the HPV vaccine” Please tell if you “Would you accept the HPV vaccine if it was recommended by… Your family? Your friends? Their teacher? Your church? A healthcare provider? Please tell me why you did not accept the HPV vaccine: Examples of options: “The HPV vaccine is not effective”, ”My daughter is not at risk of getting cervical cancer”, “I am against vaccines in general”
Please tell me why you did accept the HPV vaccine: Examples of options: “The HPV vaccine will protect my daughter's future”, “The HPV vaccine prevents my daughter from getting HPV”,
=
46 items related to HPV
By combining learnings from the qualitative research and existing HPV survey items we ensured that our questions captured the most important HPV dynamics… QUA L R E S E A RC H
E X I S T I N G S U RV E Y S
Our research revealed existing mental models around the HPV vaccine, cervical cancer and barriers to uptake. These formed the foundation for which questions to ask and the answer categories e.g., on why/why not people had accepted the vaccine. When possible, we used participants own words and descriptions to ensure the questions were understandable to the survey audience.
We reviewed existing HPV surveys and identified common categories of questions incl. fear of side effects, trust in the HPV and trust in the benefits of the vaccine to ensure we didn’t miss important categories of questions. Most HPV surveys are developed in a European or North-American context so, we did not carry any questions directly over to the Trust Survey but changed language following a no harm principle, to ensure our survey didn’t raise participants’ concerns about the HPV vaccine. 14
M E T H O D O L O G Y
|
O P E R AT I O N A L I Z AT I O N
Rather than structuring the survey strictly according to the logic of the Vaccine Trust Framework, it has been structured to have a meaningful flow for respondents The survey consists of 11 main sections SCREENING
HPV AWARENESS & VACCINATION STATUS
PERCEPTION OF THE HEALTHCARE SYSTEM
ACCESS TO HEALTHCARE SERVICES
PERCEPTION OF HEALTHCARE PROVIDERS
ATTITUDES TOWARDS HPV VACCINES
ATTITUDES TOWARDS C19 VACCINES
HEALTHSEEKING BEHAVIOR
BACKGROUND QUESTIONS AND HOUSEHOLD INFO
GENERAL TRUST QUESTIONS
157
items in total
Singlechoice
Multiplechoice
QUESTION TYPES
REDUCED FULL
Likert scales
ATTITUDES TOWARDS CHILDHOOD VACCINES
Designed for a CAPI mode of administration – taking ~45 minutes to complete
A sub-aim of this initial proof-of-concept run of the survey is to identify how best to compress it to around ~20 minutes to also be suitable for other modes of administration. Individual items/sections can also be included in other surveys.
15
M E T H O D O L O G Y
|
O P E R AT I O N A L I Z AT I O N
Key socio-demographic variables are defined based on best practice and with input from experts…
KEY DEFINITION
VA L I DAT E D S O U RC E
CAREGIVERS Adults who are responsible for the well-being of children, which could include: making financial, educational, or health-related decisions on behalf of children, being engaged in the raising, rearing, or bringing up of children, or responsible for disciplining children. The caregiver does not necessarily have to be the parent of a child.
Based on recommendation from the Ipsos team incl. LMIC survey experts
WORK Engaging in activities for which you are paid in cash or kind. The question is followed up with the question “What work do you do?” with country specific answer categories developed with input from the project’s Gender Advisors.
Based on the World Bank’s definition of work1 and adjusted based on input from the project’s Gender Advisors 1) https://databank.worldbank.org/metadataglossary/worlddevelopment-indicators/series/SL.IND.EMPL.ZS
VULNERABILITY (KE) Vulnerability in Kenya is defined according to the Pathway Vulnerability Typing Tool.
Borrowed from the Pathway Typing Tool 16
M E T H O D O L O G Y
|
T E S T
&
VA L I D AT I O N
… and different experts reviewed and provide feedback on the survey from their respective vantage points to Institutional Review Boards Consultative group composed of experts from modeling, immunization, GE, and PHC Suggested including vulnerability items from the PATHWAYS typing tool
Advisors with both subject matter, survey design, and sampling expertise Suggested a stratified multi-stage clustered sample design to enable both national and regional analyses
The survey was reviewed by an IRB in both countries and approved by relevant authorities Suggested minor language tweaks and ensure ethical standard of the survey CROSS-INSTITUTIONAL PANEL
Gender Advisors Two gender experts – specialized in Prof. Emma Varley Rhoda Maina Pakistan and Kenya respectively – have been advising the work all throughout and applied their deep contextual understanding to the survey.
Authorities in the field of vaccine confidence and HPV vaccination from the Vaccine Confidence Project incl. Professor Heidi Larrson reviewed the survey with particular attention to comparability with existing measures.
Experts from a community of interest around measuring trust in a health context – and sociobehavioral drivers more generally – provided feedback based on their own and their institutions’ experience with measuring complex social phenomena.
EXAMPLE CHANGE
EXAMPLE CHANGE
EXAMPLE CHANGE
A set of general vaccine confidence / hesitancy questions from VCP’s work were included
Sharpen question formulation and identify key trust measures to include.
Include additional categories of employment to capture different women’s experiences.
17
M E T H O D O L O G Y
|
T E S T
&
VA L I D AT I O N
The survey went through multiple rounds of testing to optimize it in terms of relevance, comprehensibility, and feasibility GENERATIVE
TESTING
• During ethnographic fieldwork • Building the survey on contextual understanding
COGNITIVE
TESTING
• 16 in-depth cognitive tests carried out • Focusing on expected challenging parts of the survey
PILOT
TESTING
• 289 tests carried out (KE = 192; PK=97) • Testing the full survey to simulate the final experience
PURPOSE
PURPOSE
PURPOSE
Getting an initial sense of people’s ability to answer trust and vaccine-related questions by testing an alphaversion of the survey that was developed based on hypotheses from the C19 work and other existing survey instruments.
Testing the comprehensibility of specific parts of the survey to assess the reliability of responses and identify issues. An example was whether respondents understood and answered based on the definition provided of “abstract” concepts such as ‘health system’.
Simulating the experience of answering the survey in its final form with a larger group of pilot respondents to identify parts for trimming, test phrasing and translations, evaluate the structure/flow/filters, and refine response categories.
EXAMPLE IMPLICATIONS
EXAMPLE IMPLICATIONS
EXAMPLE IMPLICATIONS
• Making informed decisions about whether to refer to ‘system’, ‘authorities’, or ‘providers’ • Avoiding perceived insensitive HPV questions
• It was verified that respondents generally understood and could answer in relation to the ‘health system’ and distinguish between ‘community’ and ‘hospital’ providers • Particularly in Kenya, a 5-pt response scale posed difficulties in Swahili – therefore, a 3-pt scale was used instead for most items
• Compression of a few trust sub-dimensions – e.g., skills & education weren’t sufficiently distinct to warrant separate items • Removal of a few response categories in multiplechoice matrices to make them more manageable – e.g., when asking who people trust 18
M E T H O D O L O G Y
|
S A M P L I N G
S T R AT E G Y
&
D ATA
P R O C E S S I N G
The sampling strategy was designed to produce a nationally representative sample of caregivers of children aged 10-14, plus representative samples of select areas of interest The primary goal of the study is to achieve a nationally representative sample for caregivers of children age 1014 in Kenya and Pakistan* To obtain national representation, we employed stratified multistage cluster sampling in collaboration with Ipsos Global Stratification & sample sizing: We first stratified Kenya and Pakistan into 13 and 9 strata respectively. Sample sizes prioritized six strata of interest in Kenya, and five in Pakistan. Remaining strata were allocated sample sizes proportionate to their populations with slight reductions due to prioritized areas. Selecting sampling units: We divided each stratum into primary sampling units, then secondary sampling units, and finally, blocks as the lowest cluster level Selection via random walks: At the final cluster level, we screened every kth household for adolescent children, collecting demographic information for each household. For each cluster, we conducted 8-9 interviews with qualifying households *) For security reasons, we excluded military areas in Pakistan and some areas in the Northeastern part of Kenya
The secondary goal is to produce representative samples of geographical areas of interest
PA K I S TA N
Lahore Karachi Islamabad
Azad Jammu and Kashmir Gilgit-Baltistan Balochistan
K E N YA
Nairobi Kisumu Kilifi
Kitui Isiolo Uasin Gishu
19
M E T H O D O L O G Y
|
S A M P L I N G
S T R AT E G Y
&
D ATA
P R O C E S S I N G
The definition of caregiving was kept deliberately inclusive to accommodate diverse family structures, with caregivers responding on behalf of a child in the household
We assumed a broad definition of caregiving to ensure the representation of caregivers beyond parents1
DEFINITION A caregiver is an adult who either: • • •
Makes financial, educational, or healthrelated decisions on behalf of children Engages in raising, rearing, or bringing up children Is responsible for disciplining children
ELIGIBLE
Each caregiver was asked to answer on behalf of either a boy or a girl 1) See the exact definition on the next slide 2) This practice was adopted once fieldwork had begun; first field guide version employed randomized selection with 70% chance of selection allocated to girls
SELECTED
If both a boy and a girl between the ages of 10-14 were part of the household, caregivers were asked to answer on behalf of the girl2 20
M E T H O D O L O G Y
|
S A M P L I N G
S T R AT E G Y
&
D ATA
P R O C E S S I N G
As a result, the Vaccine Trust Survey offers insight into an understudied yet crucial population— caregivers to adolescents—who are key to understand vaccine behavior W H AT W E H AV E D O N E …
W H AT O T H E R S H AV E D O N E …
Populations
Male caregivers to adolescents Female caregivers to adolescents
Vaccine behaviors
COVID-19 vaccine status HPV vaccine status Childhood vaccine status Zero dose status HPV vaccine awareness
Trust patterns
Trust in the health system promise Trust in the healthcare delivery Trust in vaccine promises Trust in vaccine delivery Interpersonal trust Institutional trust
FinAccess Household survey
Female caregiver Male caregivers × No trust data × No vaccine data Kenya 2021 & Pakistan 2018 (Wave 7)
Kenya 2021
The Social & Living Standards Measurement Survey Pakistan 2018
Kenya 2021 & Pakistan 2018
× Only childhood vaccine status children under 5yo × No HPV vaccine status × No HPV awareness × No trust data
× Only childhood vaccine status children under 3yr × No link between household data & vaccine data × No trust data
Global Monitor: Kenya 2018 & Pakistan 2018
Kenya 2022 (Round 8)
Institutional trust & interpersonal trust Trust in healthcare system × No vaccine data
Institutional trust & interpersonal trust Trust in healthcare system × No caregiver data × No vaccine data
Institutional trust & interpersonal trust Trust in healthcare system × No caregiver data × No vaccine data 21
M E T H O D O L O G Y
|
S A M P L I N G
S T R AT E G Y
&
D ATA
P R O C E S S I N G
All the results are calculated based on unweighted data to ensure transparency – and comparing weighted and unweighted results does not revealed significant differences C L E A N I N G DATA
W E I G T I N G T H E DATA
The final data set has been cleaned including the following steps:
This report presents the unweighted data to comply with best practices and ensure transparency around our results
• The data has been anonymized • Outliers have been removed based on income in Kenya • Variables have been recoded to have the same direction
There is very little difference in the trust scores in both Kenya and Pakistan when comparing the weighted and unweighted* results – suggesting a limited benefit of weighting the data PAK I STAN
”Allowing readers to understand who was interviewed and who was excluded, and to contextualize results, accordingly, may often be far more informative than any statistical adjustment done "behind the scenes".” - Collins et al. 20221
Unweighted
K E N YA
Weighted Unweighted
Weighted
Health system promise
64
64
70
71
Healthcare delivery
61
61
62
63
Vaccine promise
66
68
74
72
Vaccine delivery
71
72
70
70
*Weights are calculated based on income. The weights are available upon requests.
1) Collin et al. 2022 “Representativeness of remote methods in LMICs: A cross-national analysis of pandemic-era studies
22
Methodology
Sample composition Quantifying the Trust Framework Differences in trust Trust and the effect on vaccine uptake HPV learnings
23
C H A P T E R
O V E R V I E W
In the following chapter, we present the sample on key socio-demographic variables and vaccine rates and outline key considerations about the sample S U M M A RY
CHAPTER OUTLINE
Sociodemographic variables
Health-seeking behavior and vaccine rates
We present the sample distribution on key sociodemographic variables incl. gender, age and income
We present key statistics on health seeking-behavior incl. vaccine rates on childhood vaccines, COVID19 vaccine, and the HPV vaccine in Kenya.
Geographical spread
Sample issues and key considerations
We outline the geographical spread of the sample on a regional level
Lastly, we highlight key challenges with the sample distribution and key considerations
•
The sample consists of primarily younger female caregivers to adolescents aged 10-14
•
In both Kenya and Pakistan, the sample skews towards higher vaccination rates
•
In Kenya, the sample skews slightly toward higher-income groups
24
S A M P L E
C O M P O S I T I O N
|
S U M M A RY
S TAT I S T I C S
K E N YA
Demographic & socioeconomic profile: Randomized sampling of caregivers to adolescents has resulted in a majority of younger, female respondents K E N YA n = 3 6 7 0
Age
Income
Median 36 years
Median 10 000 KES/month
42%
PETTY TRADER/SELF-EMPLOYED
26% 16% 9%
PROFESSIONAL, TECHNICAL, MANAGERIAL HOUSEHOLD, DOMESTIC, AND SERVICES
3%
CLERICAL OR SALES
2%
OTHER
1%
UNEMPLOYED/RETIRED/HOUSEWIFE
0%
49%
>65
PROTESTANT
26%
Complete secondary
24%
CATHOLIC
14%
OTHER CHRISTIAN
13%
Incomplete secondary
11%
MUSLIM
22%
Complete primary
17%
Incomplete primary
No education
*) Past Ipsos studies give reason to believe that this split – based on random sampling of caregivers in households – is a representative reflection of the true distribution.
6%
5%
Religion 16%
Higher than secondary
6%
>25
3%
12%
Education
Type of work AGRICULTURAL
5% 45-54
BOYS
35-44
GIRLS
25-34
44%
<25
56%
SKILLED AND UNSKILLED MANUAL LABOR
6%
4%
55-64
Child gender
9%
15-25
14%
10-15
31%
22%
17%
8-10
MALE
22%
Thousand KES
6-8
FEMALE
43%
4-6
20%
2-4
80%
0-2
Respondent gender*
NONE
1%
TRADITIONAL AFRICAN
1%
OTHER
0%
25
S A M P L E
C O M P O S I T I O N
|
S U M M A RY
S TAT I S T I C S
K E N YA
Health & vaccine profile: More than half of the sample have vaccinated their daughters against HPV, while the vast majority accept childhood vaccines K E N YA n = 3 6 7 0
Public/private healthcare
COVID-19 vaccination
82%
18%
PUBLIC
PRIVATE
Type of health service used for most of respondent’s health issues
38%
YES
NO
Vaccination status of respondent
76%
24%
YES
NO
Whether respondent has heard about the HPV vaccine
Child vaccination
Type of provider
HPV vaccination
47%
LOCAL HOSPITALS
42%
HEALTH DISPENSARIES
27%
REFERRAL HOSPITALS
23%
PHARMACIST
DOCTORS WITH THEIR OWN OFFICE
62%
HPV vaccine awareness
12%
98% YES Whether child has received at least one dose of measles, hepatitis B, yellow fewer, or tuberculosis vaccine
2% NO
63%
37%
YES
NO
Whether child is vaccinated against HPV
Type of healthcare provider used for most of respondent’s health issues (multiple choice) – top 5 across respondents 26
S A M P L E
C O M P O S I T I O N
|
S U M M A RY
S TAT I S T I C S
PA K I S TA N
Demographic & socioeconomic profile: Randomized sampling of caregivers to adolescents has resulted in a majority of female respondents across income groups PA K I S TA N n = 3 7 3 4
Age Median 38 years
Respondent gender*
Type of work 30% 13%
SALARIED EMPLOYEE - GOV
11%
AGRICULTURAL
28%
Complete secondary
19%
Incomplete secondary
8%
SKILLED LABOR CULTIVATOR
7%
OTHER
6%
15%
Incomplete primary
7%
4%
UNSKILLED LABOR
1%
No education
*) Past Ipsos studies give reason to believe that this split – based on random sampling of caregivers in households – is a representative reflection of the true distribution.
20%
>150
8%
SHIA OTHER MUSLIM CHRISTIAN
Complete primary
1%
84%
SUNNI
11%
Higher than secondary
1%
Religion
21%
SALARIED EMPLOYEE - PRIVATE
3%
100-150
2%
80-100
1%
30-50
3%
15-30
45-54
35-44
12% 6%
Education
PETTY TRADER/SELF-EMPLOYED
UNEMPLOYED/RETIRED/HOUSEWIFE
25-34
BOYS
2% <25
GIRLS
20%
50-80
23%
43%
32% 27%
Child gender 57%
Thousand PKR
51%
10-15
MALE
<10
FEMALE
>65
34%
55-64
66%
Income Median 30-50 Thousand PKR/month
5% 2%
HINDU
0%
OTHER
0%
NONE
0%
27
S A M P L E
C O M P O S I T I O N
|
S U M M A RY
S TAT I S T I C S
PA K I S TA N
Health & vaccine profile: The majority of the sample is vaccinated against COVID-19 and accepts childhood vaccines for their children – while the HPV awareness is low, as expected PA K I S TA N n = 3 7 3 4
COVID-19 vaccination
Public/private healthcare
64%
36%
PUBLIC
PRIVATE
Type of health service used for most of respondent’s health issues
16%
YES
NO
5%
95% YES
NO
Whether respondent has heard about the HPV vaccine
Child vaccination
HPV vaccination
57%
DOCTORS WITH THEIR OWN OFFICE
44%
REFERRAL HOSPITALS
38%
LOCAL HOSPITALS
LADY HEALTH WORKER
84%
Vaccination status of respondent
Type of provider
LOCAL HEALTH CLINIC
HPV vaccine awareness
17% 15%
91%
9%
YES
NO
N/A
Whether child has received at least one dose of measles, hepatitis B, yellow fewer, or tuberculosis vaccine
Type of healthcare provider used for most of respondent’s health issues (multiple choice) – top 5 across respondents 28
S A M P L E
C O M P O S I T I O N
|
S U M M A RY
S TAT I S T I C S
Geographically, the sample ensures representation across Kenya and Pakistan, including hard-toreach populations in the North Eastern Kenyan region and Balochistan in Pakistan PA K I S TA N
K E N YA
G I L G I T
R I F T
VA L L E Y
E A S T E R N N O R T H
298
461 514
156
K B Y B E R
688
E A S T E R N
W E S T E R N
B A L T I S T A N
869
P A K H T U N K W H A
119
A Z A D &
417
J A M M U
K A S H M I R
153
C E N T R A L N YA N Z A
369 352
P U N J A B
1697
N A I R O B I
B A L O C H I S T A N
C O A S T
S I N D H
178
978
29
S A M P L E
C O M P O S I T I O N
|
S U M M A RY
S TAT I S T I C S
Sample issue - higher income in Kenya: Our randomized sample of caregivers of adolescents skews towards higher vaccination rates and higher incomes compared to general population benchmarks K E N YA
Income 10 000 KES/month 22%
Thousand KES 12%
• 26% of sample below national poverty lines: Despite the apparent skew toward higher income, our sample does represent low-income caregivers using the Kenya Bureau of Statistic’s poverty lines for urban and rural areas2
>25
5% 15-25
6-8
4-6
6%
8-10
9%
2-4
0-2
6%
22%
17%
10-15
Median
We have reason to believe that this relative skew toward higher incomes represents our population of caregivers
*) See appendix for sampling strategy + full sample composition
Income In 2021, the median income for parents (of children of all ages) was 5.000 KES/month (FinAccess) 1
1) FinAccess, 2021: “FinAccess 2021”. Median income calculated based on full dataset, see https://finaccess.knbs.or.ke/reports-and-datasets
• Our sample ended-up oversamples urban, and in turn, richer populations. Our sample design oversamples urban populations who generally have higher incomes.3 • Our sample population is likely to be professionally active. Parents to adolescents are often in the most productive age (mid twenties to late forties) (see appendix), and, therefore, more likely to be part of the workforce than other population groups. • The most recent benchmark contains data from mid-C19-pandemic when poverty in Kenya peaked, suggesting that the benchmark available may provide an underestimate of income levels for 20234
2) Kenya Bureau of Statistics (2021) defines poverty line as Ksh 3,947 and Ksh 7,193 per person per month for rural and urban areas respectively in World Bank 2023: Kenya Poverty and Equity Assessment 2023, https://documents.worldbank.org/en/publication/documents-reports/documentdetail/099121323073037589/p1773530a7eb3009308e3f08663aa95c826 3) World Bank 2023: Kenya Poverty and Equity Assessment 2023, https://documents.worldbank.org/en/publication/documents-reports/documentdetail/099121323073037589/p1773530a7eb3009308e3f08663aa95c826 4) World Bank 2023: Kenya Poverty and Equity Assessment 2023, https://documents.worldbank.org/en/publication/documents-reports/documentdetail/099121323073037589/p1773530a7eb3009308e3f08663aa95c826 30
I N T R O D U C T I O N
T RU S T
DATA
Sample issue - higher vaccine coverage: In both Kenya and Pakistan, our randomized sample of caregivers of adolescents skews towards higher vaccination rates K E N YA
PAK I STAN
Vaccination rates
Vaccination rates
COVID-19 vaccination (of respondent)
COVID-19 vaccination (of respondent)
62%
38%
84%
16%
YES
NO
YES
NO
Childhood vaccination (of child)
Childhood vaccination (of child)
98%
2%
YES
91%
9%
YES
NO
NO
EXTERNAL DATA
HPV vaccination (of child) 63%
37%
YES
NO
HPV vaccine rate
COVID-19 vaccine
Childhood vaccine
COVID-19 vaccine rate
33% have received the first dose and 16% have received the second by 20221.
Childhood vaccine rate
Approx. 32% of adults had received two doses by 20222.
Approx. 68%3 of children are vaccinated.
Approx. 64% of the population has received two doses.4
The national vaccine rate is approx. 76% 5
1) Karanja-Chenge, Christine Muthoni, 2022: “HPV Vaccination in Kenya: The Challenges Faced and Strategies to Increase Uptake. Front Public Health. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978582/ 2) Statista, 2022: “Share of adult population fully vaccinated against COVID19 in Kenya as of July 9 2022, by county”. https://www.statista.com/statistics/1252641/share-of-population-fully-vaccinated-against-covid-19-in-kenyan-counties/ 3) Allen et al., 2023: Inequalities in childhood immunization coverage associated with socioeconomic, geographic, maternal, child and place of birth characteristics in Kenya. BMC Infectious Diseases . https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-021-06271-9/tables/
We have reason to believe that this relative skew toward higher vaccination rates reflects our population of caregivers of adolescents • Our sample population is likely to be one of the most active groups of society. Parents to adolescents are often in the most productive age (mid twenties to late forties), and so, some of the most active citizens • Our sample oversamples urban populations in both Kenya and Pakistan—a subpopulation that historically has been easier to reach in vaccine interventions. • Most recent benchmarks contain data from 2022. With data collection taking place in late 2023, vaccination rates for especially C19 and HPV may have improved since most recent benchmarks
4) Reuters COVID-19 Tracker, 2022: “Pakistan”. https://www.reuters.com/graphics/world-coronavirus-tracker-and-maps/countries-and-territories/pakistan/ 5) Unicef, 2021: “Country Office Annual Report 2021”. https://www.unicef.org/media/116341/file/Pakistan-2021-COAR.pdf
31
Methodology Sample composition
Quantifying the Trust Framework Differences in trust Trust and the effect on vaccine uptake HPV learnings
32
C H A P T E R
O V E R V I E W
In the following chapter, we build and test the validity of the Vaccine Trust Framework and its constitutive parts S U M M A RY
CHAPTER OUTLINE
Approach to building the Vaccine Trust Framework
Kenya and Pakistan’s Vaccine Trust Scores
We demonstrate how the Trust Framework is quantified bottomup, from questions to trust components.
We present the national trust scores for Kenya and Pakistan.
Imputing HPV vaccine trust in Pakistan
Testing the validity of the Vaccine Trust Framework
We impute HPV vaccine trust in Pakistan by using C19 and childhood vaccines as proxies.
We test the internal and external validity of the Vaccine Trust Framework to ensure its statistical existence.
The Vaccine Trust Framework is quantified bottom-up, and the imputed HPV vaccine trust score is calculated for Pakistan by averaging trust in childhood and the C19 vaccine. The validation of the Trust Framework confirms that the Trust Framework exists statistically speaking, and that its major components, levels and quadrants, for the most part strike a balance between consistency (correlation) and distinctiveness (holding unique variation in explaining trust as a phenomenon).
33
Q U A N T I F Y I N G
T H E
F R A M E W O R K
|
A P P R O A C H
The Vaccine Trust Framework assumes that each individual has their own trust profile and scores – aggregating the individual trust scores yields the trust score T RU S T S C O R E S RESPONDENT 1
T RU S T S C O R E S RESPONDENT 2
T RU S T S C O R E S RESPONDENT 3
71
74
68
65
75
68
67
70
73
51
72
54
K E N YA’ S
T RU S T
70
SCOR
74
69 67
64
70
72
The trust score is reported on a scale from 0 – 100, with 0 indicating low trust, and 100 indicating high trust*. * Statistically the trust score is normalized to a scale on 0 – 1, before being multiplying with 100 34
Q U A N T I F Y I N G
T H E
F R A M E W O R K
|
A P P R O A C H
To calculate the trust score, the Vaccine Trust Framework is quantified bottom-up progressing from dimensions, quadrants, levels, and ultimately, the full framework
From indicators to dimensions
From dimensions to quadrants
From quadrants to levels
Each dimension consists of a number of indicators, i.e., questions included in the survey
The Framework’s trust quadrants aggregate the scores of the trust dimensions for the quadrant in question
The level scores for the health system and vaccines respectively aggregate the quadrants that connect vertically
The full Trust Framework
35
Q U A N T I F Y I N G
T H E
F R A M E W O R K
|
A P P R O A C H
Out of the 150 questions included in the survey, 50 questions serve as indicators for the trust scores that aggregate into a trust score at the dimension level S U RV E Y Q U E S T I O N S
Please tell me if you do not at all agree, somewhat agree, or strongly agree: “The healthcare system prioritizes my good health” Please tell me if you do not at all agree, somewhat agree, or strongly agree: “The healthcare system prioritizes the health issues that are most important for me and my community”
PRIORITY ALIGNMENT
0 Low trust
77
100 High trust
The trust score is reported on a scale from 0 – 100, with 0 indicating low trust, and 100 indicating high trust*.
By averaging the values, we obtain a unified index for each trust dimension
Each dimension consists of 1-9 indicators * Statistically the trust score is normalized to a scale on 0 – 1, before being multiplying with 100 36
Q U A N T I F Y I N G
T H E
F R A M E W O R K
|
A P P R O A C H
The scores on dimensions are aggregated into the trust score on a quadrant level, again by averaging the individual’s trust score
64
PRIORITY ALIGNMENT
77
T RU S T S C O R E AT T H E Q UA D R A N T L E V E L
By calculating the average of the four dimensions that make up the quadrant for each individual and aggregating them, we obtain the trust score at the quadrant level —in this case, for trust in the health system promise
AUTONOMY
CAPA BI LI T Y FAIRNESS
77
49
51
37
Q U A N T I F Y I N G
T H E
F R A M E W O R K
|
A P P R O A C H
Averaging the two quadrant scores for the health system or the vaccine produces the trust score at either the health system or vaccine level 77 49
64 T RU S T
SCORE
51
77 H E A LT H
S YS T E M
H E A LT H C A R E
60 T RU S T
P RO M I S E
D E L I V E RY
T RU S T S C O R E AT T H E H E A LT H S YS T E M L E V E L
71 SCORE
73
62
51
47 56
In this case, we have calculated the trust score at a health system level by averaging each individual’s trust scores at the quadrant level
38
Q U A N T I F Y I N G
T H E
F R A M E W O R K
|
A P P R O A C H
92 By combining the two levels, we obtain the full Vaccine Trust Framework and the trust scores at the vaccine and system 77level
64 QUA DR ANT LEVEL
QUA DR ANT LEVEL
53
S YS T E M
H E A LT H C A R E
P RO M I S E
VA C C I N E
D E L I V E RY
VA C C I N E
71
QUADRANT SCORE
62
69
51
77 H E A LT H
60
63
49
HEALTH SYSTEM LEVEL
70 73
51
47 56
61
80
P RO M I S E D E L I V E RY
70
QUA DR ANT LEVEL
70
VA C C I N E L E V E L 39
Q U A N T I F Y I N G
T H E
F R A M E W O R K
|
T R U S T
S C O R E S
K E N YA
gn ali
omy
es riti
Be nef it
io Pr
n Auto
This approach produces the following framework and trust scores for Kenya, with the vaccine level for the HPV vaccine n me t
Ca pa
70 S Y S T E M
P RO M I S E
D E L I V E RY lity dentia Confi
on De liv er y
bility
ss
Afford a
HEALTH SYSTEM LEVEL
ssi
Ac ce
a mp Co
ty
se t
tin
g
74
VA C C I N E
P RO M I S E
VA C C I N E
D E L I V E RY
Adeq u
cy en Ag
66
s
en ce
62
e Saf
pe t
H E A LT H C A R E
nes
e nc
bil ity
Co m
H E A LT H
Fair
va le Re
acy o f info
70
72
VA C C I N E L E V E L 40
Q U A N T I F Y I N G
T H E
F R A M E W O R K
|
T R U S T
S C O R E S
K E N YA
n Auto
io Pr gn ali
omy
es riti
Be nef it
…And a total trust score of 69, compounding the health system and vaccine level
n me t
S Y S T E M
lity dentia Confi
HEALTH SYSTEM LEVEL
ssi
on
e Saf
ss
ty
eli ve ry
se t
tin
g
74
VA C C I N E
P RO M I S E
VA C C I N E
D E L I V E RY
Adeq u
G E N E R A L T R U S T S C O R ED
Ac ce
a mp Co
cy en Ag
66
69
D E L I V E RY
en ce
62
P RO M I S E
pe t
H E A LT H C A R E
s
Co m
H E A LT H
nes
bility
70
Fair
e nc
bil ity
Afford a
Ca pa
va le Re
acy o f info
70
72
VA C C I N E L E V E L 41
Q U A N T I F Y I N G
T H E
F R A M E W O R K
|
T R U S T
S C O R E S
PA K I S TA N
gn ali
o my
es riti
Be nef it
io Pr
n Auto
In Pakistan, the HPV vaccine remains to be rolled out—which, at first, leaves us with the trust score at the health system level alone n me t
ce an ev l Re
Ca pa
64 S Y S T E M
ty
P RO M I S E
D E L I V E RY lity dentia Confi
De liv er y
se t
tin g
ability Afford
ncy
HEALTH SYSTEM LEVEL
acy o f info
i on ss
Ac ces s
a mp Co
Adeq u
e Ag
62
s
ce
61
e Saf
en
H E A LT H C A R E
nes
Co m pe t
H E A LT H
Fair
bi l ity
42
Q U A N T I F Y I N G
T H E
F R A M E W O R K
|
I M P U T I N G
H P V
R E S P O N S E
However, we have observed that the HPV vaccine occupies a space between childhood and adult vaccines in fieldwork—and we see a similar pattern in the Kenyan survey data During fieldwork, we observed how the HPV vaccine occupied its own space in respondents’ mental models around vaccines…
This informed the hypothesis that trust in the HPV vaccine is neither entirely correlated with C19, nor childhood vaccines 1 – trust in HPV vac.
1 - trust in HPV vac.
1 – Trust in childhood vac.
βC19 0.24 βchildhood 0.68
Fieldwork in this project’s earlier phase suggested that the HPV vaccine targeting adolescent girls carries potential adult connotations while still being a vaccination decision made by caregivers on behalf of a child
βC19 0.55
0 Trust in Childhood vac. - 1
0
P-value <0.0001
P-value <0.0001
Trust in C19 vac. - 1
0
Trust in C19 vac. - 1
P-value <0.0001
Both childhood and C19 vaccine items help explain unique variation in the response to the HPV vaccine in Kenya and remain significant when included in the same model —supporting the interpretation that both vaccine items can be used to impute HPV responses 43
Q U A N T I F Y I N G
T H E
F R A M E W O R K
|
I M P U T I N G
H P V
R E S P O N S E
With this in mind, we can impute the response to the HPV vaccine by averaging trust levels in COVID-19 and childhood vaccines B E N E F I T
T E S T I N G M E T H O D I N K E N YA
R E L E VA N C E
When averaging trust in childhood and C19 vaccines in Kenya to impute trust in the HPV vaccine, we find that each imputed dimension varies by a maximum of +/- 10 in trust score compared to observed scores
S A F E T Y
C AV E AT S
Pulling the average assumes that the context observed in Kenya—HPV occupying its own space due to its target group being adolescents—is also applicable to Pakistan.
FINDING
A D E QUAC Y O F I N F O
D E L I V E RY S E T T I N G S AG E N C Y
Calculating the average trust in childhood and C19 vaccines provides a relatively accurate picture of the observed HPV response in Kenya
Observed HPV response
An estimate based on childhood vaccines and C19 unifies two types of vaccines with diverse timelines, presenting a challenge in pinpointing when the imputed trust levels for the HPV vaccine would materialize. In particular trust in childhood vaccines appears to contribute to a slight overestimation of trust in the HPV vaccine.
Imputed HPV response 44
Q U A N T I F Y I N G
T H E
F R A M E W O R K
|
T R U S T
S C O R E S
PA K I S TA N
fit Be ne
en nm lig sa
o my
itie ior Pr
n Auto
This method provides us with the following framework and trust scores for Pakistan, including imputed trust scores for the vaccine level t
ce an ev l Re
Ca pa
64 S Y S T E M
lity dentia Confi
De liv er y
bility Afford a
HEALTH SYSTEM LEVEL
n sio
ss
as mp Co
ty
se t
tin g
66
VA C C I N E
P RO M I S E
VA C C I N E
D E L I V E RY
Adeq uacy of
cy en Ag
63
D E L I V E RY
Ac ce
61
P RO M I S E
nc e
H E A LT H C A R E
e Saf
Fair nes s
Co m pe te
H E A LT H
bil ity
info
71
68
VA C C I N E L E V E L 45
Q U A N T I F Y I N G
T H E
F R A M E W O R K
|
T R U S T
S C O R E S
PA K I S TA N
o my
en nm lig sa
Be ne
n Auto
itie ior Pr
fit
…And a compound trust score of 66 for Pakistan
t
ce an ev l Re
S Y S T E M
HEALTH SYSTEM LEVEL
n sio
e Saf
ty
el ive ry
se t
tin g
66
VA C C I N E
P RO M I S E
VA C C I N E
D E L I V E RY
Adeq uacy of
G E N E R A L T R U S T S C O R ED ss
as mp Co
cy en Ag
63
66
lity dentia Confi
Ac ce
61
D E L I V E RY
nc e
H E A LT H C A R E
P RO M I S E
Co m pe te
H E A LT H
Fair nes s
bility
64
bil ity
Afford a
Ca pa
info
71
68
VA C C I N E L E V E L 46
Q U A N T I F Y I N G
T H E
F R A M E W O R K
|
I N T E R N A L
VA L I D AT I O N
The Trust Framework’s components are interrelated, but also all uniquely necessary to conceptualize trust—striking a balance between consistency and distinctiveness
FUL LY DI STI NC T
F U L LY C O N S I S T E N T
Producing fully consistent quadrants and dimensions, i.e., obtaining perfect correlation, would indicate that the Framework’s different components are obsolete
CRITERIA 1
The Trust Framework
Within a level & quadrant
Striking a balance between consistency and distinctiveness within a quadrant, i.e., ensuring that dimensions contribute to measuring a specific type of trust
CRITERIA 2
Producing fully distinct quadrants and dimensions, i.e., obtaining zero correlation, would indicate that the Framework’s components do not measure the same phenomena
Between quadrants
Striking a balance between consistency and distinctiveness between quadrants, i.e., ensuring that all four kinds of trust are in fact related and needed to conceptualize trust as a whole
47
Q U A N T I F Y I N G
T H E
F R A M E W O R K
|
I N T E R N A L
VA L I D AT I O N
|
W I T H I N
L E V E L S
Within levels: Dimensions are more closely connected within each level on average, suggesting that the Framework’s health system and vaccine levels are statistically consistent
HEA LT H S YSTE M
HEA LTH SYS TEM LE VEL
Autonomy Priority alignment Capability Fairness Confidentiality Compassion Competence Access Affordability
VA C C I N E
Benefit Relevance Safety Adequacy of info Delivery setting Agency
VA C C I N E L E V E L
Autonomy
Priority alignment
Capability
Fairness
Confidentiality
Compassion
Competence
Access
Affordability
Benefit
Relevance
Safety
NA
0.21
0.07
0.10
0.24
0.17
0.08
0.19
0.09
0.11
0.10
0.09
0.16
0.16
0.06
0.21
NA
0.26
0.04
0.17
0.29
0.11
0.17
0.09
0.14
0.11
0.09
0.19
0.22
0.12
0.07
0.26
NA
-0.05
0.11
0.24
0.17
0.18
0.15
0.08
0.06
0.12
0.15
0.16
0.14
0.16
NA
0.12
0.07
0.05
0.12
0.16
0.24
0.11
0.13
0.12
0.31
0.23
0.10
0.15
0.11
0.08
0.13 0.04 Average correlation NA within the health 0.37 0.04 0.37 NA system level
0.06
0.13
Average correlation between 0.04 0.09 0.04 0.04 vaccine0.15 dimensions and 0.06 0.08 0.17 dimensions 0.15system 0.18 0.23 0.07
0.06
0.16
0.31
NA
0.16
0.14
0.07
0.07
0.13
0.15
0.11
0.11
0.24
0.23
0.16
NA
0.33
0.10
0.08
0.09
0.11
0.09
0.05
0.10
0.10
Adequacy of info Delivery setting
Agency
0.04
-0.05
0.17
0.11
0.29
0.24
0.11
0.17
0.19
0.17
0.18
0.12
0.09
0.09
0.15
0.07
0.11
0.10
0.14
0.33
NA
-0.01
0.00
0.09
0.07
0.03
0.05
0.11
0.14
0.08
0.05
0.13
0.15
0.07
0.10
-0.01
NA
0.43
0.22
0.29
0.40
0.13
0.10
0.11
0.06
0.12
0.12
0.11
0.07
0.08
0.00
0.43
NA
0.27
0.31
0.29
0.07
0.09
0.10
0.09
0.09
0.22
0.27
0.24 0.17
0.16 0.16 0.06
0.09
0.12
0.19
0.15
0.22
0.16
Average correlation between 0.13 0.08 0.15 vaccine dimensions and 0.09 0.15 0.18 0.15 system dimensions 0.04 0.17 0.23 0.11
0.12
0.14
0.04
0.04
0.06
0.07
0.11
0.29
0.11
0.07
0.29
0.31
0.09
0.03
0.40
0.29
0.05
0.05
0.13
0.07
0.08 Average correlation 0.28 0.41 withinNAthe vaccine level 0.24 NA
0.28
0.29
0.29
0.41
NA
0.33
0.08
0.24
0.33
NA 48
Q U A N T I F Y I N G
T H E
F R A M E W O R K
|
I N T E R N A L
VA L I D AT I O N
|
W I T H I N
Q U A D R A N T S
Within quadrants: Using the Vaccine Trust Framework to allocate dimensions, we improve internal correlation in three out of four quadrants compared to distribution at random P RO C E D U R E
RESULTS Avg. correlation (at random)
While we have qualitative reason to group dimensions as per the Vaccine Trust Framework, we also tested internal consistency within quadrants by comparing internal quadrant correlation with the correlation coefficient had the dimensions been distributed at random.
Avg. correlation within true quadrant
Change (%)
Health system promise
0.15
0.10
-29%
Healthcare delivery
0.15
0.22
48%
Vaccine promise
0.15
0.31
111%
Vaccine delivery
0.15
0.32
122%
Health system promise is the only quadrant that doesn’t improve its internal correlation when compared with the random distribution. This is expected as the quadrant is the most abstract and difficult to measure, compounding large concepts such as fairness and autonomy. 49
Q U A N T I F Y I N G
T H E
F R A M E W O R K
|
I N T E R N A L
VA L I D AT I O N
|
W I T H I N
Q U A D R A N T S
Within quadrants: Health system promise has relatively low internal consistency due to two dimensions showing negative correlation—a challenge the Vaccine Trust Tool will address Two dimensions in Health system promise, Capability and Fairness, are negatively correlated, resulting in a reduced correlation score for this quadrant Autonomy
Priority alignment
Capability
Fairness
The Trust Tool aims to shed light on this dynamic through re-operationalization of Fairness The observed negative correlation could indicate a scenario in which some respondents view the health system as capable of treating illnesses, but also experience that they are to some extent excluded from treatment because of socio-demographic markers such as ethnicity, gender, and geography.
Autonomy
1
0.21
0.07
0.10
Priority alignment
0.21
1
0.26
0.04
Capability
0.07
0.26
1
-0.05
Notably, Fairness represents a complex dimension that by definition could negatively correlate with other dimensions e.g. capability as people might evaluate the health system positively for others than themselves.
Fairness
0.10
0.04
-0.05
1
To examine this, the Vaccine Trust Tool will revisit the operationalization of dimensions to clarify this dynamic.
CURRENT C A P A B I L I T Y
VERSIONS F A I R N E S S
Being treated differently in the health system because of …
REVISED
VERSION
F A I R N E S S
Being treated more poorly in the health system because of… PROPRIETARY AND CONFIDENTIAL | 50
Q U A N T I F Y I N G
T H E
F R A M E W O R K
|
I N T E R N A L
VA L I D AT I O N
|
B E T W E E N
Q U A D R A N T S
Between quadrants: We find that the quadrants hold unique variation when fitted in the same regression model—indicating that they are related, but also distinct RESULTS
P RO C E D U R E
System
Independent variable II
Vaccine
Independent variable I
All quadrants hold unique variation
Dependent variable
Independent variable III
To test relatedness and distinctiveness between quadrants, we fit four regression models with one quadrant as the ‘dependent’ variable and the remaining three quadrants as independent variables, assessing whether they all hold unique variation when predicting the last quadrant
All quadrants are highly significant (p-values < 0.0001) in all models. As expected, same-level quadrants produce higher coefficients, and opposite-level quadrants slightly lower coefficients. OLS Dep: Health System Promise
RESULTS*
C O E F.
Dep: Vaccine promise
C O E F.
Healthcare delivery
0.42
Health system promise
0.09
Vaccine promise
0.06
Healthcare delivery
0.14
Vaccine delivery
0.1
Vaccine delivery
0.29
Dep: Healthcare delivery
C O E F.
Dep: Vaccine delivery
C O E F.
Health system promise
0.27
Health system promise
0.24
Vaccine promise
0.05
Healthcare delivery
0.19
Vaccine delivery
0.05
Vaccine promise
0.43
*) Intercepts omitted for simplicity
51
Q U A N T I F Y I N G
T H E
F R A M E W O R K
|
I N T E R N A L
VA L I D AT I O N
|
M U LT I C O L L I N E A R I T Y
Our data shows multicollinearity between the four trust quadrants—but results remain statistically significant throughout when predicting vaccination behavior The Vaccine Trust Framework conceptualizes trust as four related trust types, making multicollinearity a premise for analysis The trust quadrants display low to moderate pairwise correlation—however, Variance Inflation Factors (VIF) are high (+10), suggesting that the combination of trust quadrants drive multicollinearity, and in turn, increases statistical uncertainty of results PA I RW I S E C O R R E L AT I O N * Health promise
Healthcare delivery
Vaccine promise
VIF ANALYSIS* Vaccine delivery
Health promise
20
Health promise
1
0.4
0.2
0.26
Healthcare delivery
21
Healthcare delivery
0.4
1
0.19
0.22
Vaccine promise
14
Vaccine promise
0.2
0.19
1
0.4
Vaccine delivery
11
Vaccine delivery
0.26
0.22
0.4
1
*) Calculated based on results from Kenya on the HPV vaccine
Despite multicollinearity, we observe significant results across analyses of the four trust quadrants This indicates that although results are subject to higher statistical uncertainty, trust comes out as a strong predictor of vaccine uptake.
52
Q U A N T I F Y I N G
T H E
F R A M E W O R K
|
E X T E R N A L
VA L I D AT I O N
External validation: Compared to other widely used trust measures, the Vaccine Trust Tool turns out to add signficantly more explanation to variations in vaccine uptake Interpersonal trust measures are not helpful in explaining variation in vaccine uptake, producing statistically insignificant results. For the Vaccine Trust Tool, the correlations are stronger and highly significant indicating a strong relationship between trust and vaccine uptake.
Logistical regression correlations between vaccine uptake and different trust measures reported in log odds
C19 vaccine uptake
Interpersonal trust2
NOT
0.13
INTERPERSONAL TRUST
Interpersonal trust is a widely used and accepted measure of trust in the trust literature – often applied in studies on health-seeking behaviors and vaccine uptake. The question: “Generally speaking, would you say that most people can be trusted or that you need to be very careful in dealing with people?” stems from the World Value Survey1.
1) World Value Survey Wave 7 (2017-2022). Documentation: The questionnaire. https://www.worldvaluessurvey.org/WVSDocumentationWV7.jsp
Childhood vaccine uptake
HPV vaccine uptake
SIGNIFICANT
0.19
-0.17
SIGNIFICANT
Vaccine Trust Tool3
2.58***
1.42**
3.68***
Correlations are controlled for respondent gender, age, educational attainment, language, religion and province. **p<0.01; ***p<0.001 2) Measured by the binary question “Generally speaking, would you say that most people can be trusted or that you must be very careful in dealing with people? ” 3) Measured as a combined measure of the four trust quadrants in the Vaccine Trust Framework: Trust in the health system promise, the healthcare delivery, the vaccine promise, and the vaccine delivery.
53
Methodology Sample composition Quantifying the Trust Framework
Differences in trust Trust and the effect on vaccine uptake HPV learnings
54
C H A P T E R
O V E R V I E W
In the following chapter, we test differences in trust across a range of socio-demographic and vaccine behaviors CHAPTER OUTLINE
S U M M A RY
Gender
Women: employment status
Caregivers of boys/girls
Education
Income: Above or below the poverty line
Survey language
Regions
Rural/urban
Vulnerability
Zero doses and vaccine rejectors
Null findings
People don’t trust uniformly across Kenya and Pakistan – women are more trusting than men, regions such as North Eastern in Kenya and Balochistan and Sindh in Pakistan are less trusting, and marginalized groups such nondominant language speakers are less trusting.
We explore differences in trust across demographic and socio-economic groups on a quadrant and dimension level 55
I N T R O D U C T I O N
T O
T H E
VA C C I N E
T R U S T
S C O R E
The reported vaccine trust score is calculated based on the HPV vaccine in Kenya, and an average trust score across vaccines in Pakistan K E N YA
PA K I S TA N
For Kenya, the reported trust scores are calculated based respondents’ answers to HPV vaccine specific questions
For Pakistan, the reported trust scores are an average calculated across respondents’ answers to COVID-19 and childhood vaccine specific questions
The Vaccine Trust Survey was designed for HPV specificities and included more questions on HPV compared to other vaccines. As a result, trust scores on HPV are more granular than other vaccines, and the results are, therefore, reported on HPV when possible.
In Pakistan, the HPV vaccine hasn’t been introduced, and its, therefore, not possible to report trust scores on it. Instead, the reported trust scores are an average across vaccines to ensure the most precise results
VACCINE OPTIONS TO REPORT TRUST SCORES ON IN THE TRUST DATA:
The trust scores can easily recalculate based on different vaccines depending on the objective of a particular analysis. KENYA
PA K I S TA N
The HPV vaccine
The COVID19 vaccine
The COVID19 vaccine Childhood vaccines Average vaccine trust across HPV, COVID19 and childhood vaccines
Childhood vaccines Average vaccine trust across COVID19 and childhood vaccines
56
B E H AV I O R A L
H Y P O T H E S E S
D I F F E R E N C E S
I N
T R U S T
|
G E N D E R
FINDING
KENYA
Women are significantly more trusting than men across all trust quandrants
Testing gender differences across quadrants
T O TA L T RU S T
Women Men
70 65
QUADRANTS
OVERALL DIFFERENCE
Health system promise
71
66
5 points (p<0.01)
Healthcare delivery
63
59
4 points (p<0.01)
Vaccine promise
75
70
Vaccine delivery
71
68
n = 2946
n = 724
Women trust the health system promise more than men
Women healthcare delivery more than men
5 points (p<0.01)
Women trust the vaccine promise on more than men
5 points (p<0.05)
Women trust the vaccine delivery more than men
INTERPRETATION
Our qualitative research did not yield any specific hypotheses in differences among men and women. However, we see that women are significantly more trusting than men across all four trust quadrants – this is not due to more healthcare interaction or exposure to the healthcare system. 57
B E H AV I O R A L
H Y P O T H E S E S
D I F F E R E N C E S
I N
T R U S T
|
G E N D E R
FINDING
KENYA
Across dimensions, women are more trusting than men— especially in Priority Alignment, Compassion, and Relevance
Testing gender differences by dimension
T O TA L T RU S T
Women Men
70 65
QUADRANTS
Health system promise
Healthcare delivery
Vaccine promise
Vaccine delivery
Autonomy
Priority alignment
Capability
Fairness
76
79
52
77
71
71
48
75
Confidentiality
Compassion
Competence
Access
Affordability
83
75
51
57
48
79
68
50
54
45
Benefit
Relevance
Safety
89
74
54
86
67
50
Adequacy of info
Delivery settings
Agency
71
77
61
n = 2946
70
71
65
n = 724
INTERPRETATION
Results indicate that women especially experience more Priority alignment with the HCS than men, as well as greater autonomy over health decisions Disparity in experienced Compassion of providers contributes the most to women having higher trust in healthcare delivery than men Perceived Relevance of the vaccine for the child contributes the most to women having higher trust in the vaccine promise
Results indicate that observed difference in vaccine delivery trust is driven by varying attitudes to Delivery settings. Notably, while women appear to experience less agency than men, this difference is not significant.
α = 0.05 or smaller; greyed out are not significant 58
B E H AV I O R A L
H Y P O T H E S E S
D I F F E R E N C E S
I N
T R U S T
|
G E N D E R
FINDING
PAK I STAN
Women in Pakistan are significantly more trusting than men across all trust quadrants—and especially in vaccine delivery
Testing gender differences across quadrants
T O TA L T RU S T
Women Men
69 64
QUADRANTS
OVERALL DIFFERENCE
Health system promise
66
61
4 points (p<0.01)
Healthcare delivery
60
58
2 points (p<0.01)
Vaccine promise
67
63
Vaccine delivery
73
68
n = 2482
n = 1252
INTERPRETATION
Women trust the health system promise more than men
Women trust healthcare delivery more than men
4 points (p<0.01)
Women trust the vaccine promise more than men
5 points (p<0.01)
Women trust the vaccine delivery more than men
Our qualitative research did not yield any specific hypotheses on differences among men and women. However, we see that women are significantly more trusting than men across all four trust quadrants – this is not due to more healthcare interaction or exposure to the healthcare system (controlled).
59
B E H AV I O R A L
H Y P O T H E S E S
D I F F E R E N C E S
I N
T R U S T
|
G E N D E R
FINDING
PAK I STAN
Across dimensions, women continue to hold higher trust scores than men— except for Affordability of healthcare.
Testing gender differences by dimension QUADRANTS
Health system promise
Healthcare delivery
T O TA L T RU S T
Women Men
69 64
Vaccine promise
Vaccine delivery
Autonomy
Priority alignment
Capability
Fairness
77
67
59
61
72
65
52
54
Confidentiality
Compassion
Competence
Access
Affordability
74
69
52
58
46
70
61
51
59
48
Benefit
Relevance
Safety
85
54
61
80
55
55
Adequacy of info
Delivery settings
Agency
75
82
66
n = 2482
68
74
65
n = 1252
INTERPRETATION
Women’s higher trust levels in this quadrant is especially driven by greater perceived Fairness of the system, but also experienced Autonomy over health decisions and the system’s Capability to treat Disparity in experienced Compassion of providers contributes the most to women having higher trust in healthcare delivery than men. Notably, women score lower on the affordability of healthcare Both perceived Benefit and Safety of the vaccine contribute the most to women having higher trust in the vaccine promise
The observed difference between men and women is driven by different attitudes towards Delivery settings for vaccinations, as well as differing experiences of having received Adequate information
α = 0.05 or smaller; greyed out are not significant 60
B E H AV I O R A L
H Y P O T H E S E S
D I F F E R E N C E S
I N
T R U S T
|
G E N D E R
|
E M P L O Y M E N T
S TAT U S
FINDING
K E N YA
Women outside the professional labor force exhibit significant lower trust in both healthcare and vaccine delivery than women who are employed.
Testing differences between employed and unemployed* women QUADRANTS
Health system promise
EMPLOYED
71
UNEMPLOYED
71
DIFFERENCE
No significant difference DISPARITY
Healthcare delivery
63
61
-2 points
Vaccine promise
75
74
No significant difference
(p<0.01)
Confidentiality
84
80
p<0.01
Access
58
54
p<0.01
Delivery setting
79
72
p<0.01
Agency
63
52
p<0.01
DISPARITY
T O TA L T RU S T
Employed women Unemployed women
70 68
Vaccine delivery INTERPRETATION
72
67
n = 2178
n = 766
-5 points (p<0.01)
The results indicate that women outside the professional labor force experience greater barriers when it comes to the process of receiving healthcare as well as the process surrounding the HPV vaccine. Most notably, women outside experience less agency, i.e., a lack of consent when it comes to the HPV vaccine (-11 points compared to employed women), as well as lower trust in the delivery settings. A possible explanation for this is that this group of women has lower trust in the schools used as vaccination sites, including the process around giving consent, i.e., Agency. *By unemployed we mean women who don’t “engage in activities for which you are paid in cash or kind”.
61
B E H AV I O R A L
H Y P O T H E S E S
D I F F E R E N C E S
I N
T R U S T
|
G E N D E R
|
E M P L O Y M E N T
S TAT U S
FINDING
PAK I STAN
Women outside the professional labor force exhibit lower trust in the vaccine delivery, i.e., C19 vaccine, driven by lacking trust in agency compared to formally employed women.
Testing differences between employed and unemployed* women QUADRANTS
EMPLOYED
UNEMPLOYED
DIFFERENCE
Health system promise
65
66
No significant difference
Healthcare delivery
61
62
No significant difference
Vaccine promise
71
69
No significant difference on dimension level DISPARITY
T O TA L T RU S T
Employed women Unemployed women
69 69
Vaccine delivery INTERPRETATION
76
71
n = 226
n = 2251
-5 points (p<0.01)
Agency
73
66
p<0.01
We expected that unemployed women would be less in contact with the official system, and with limited experience with the system potentially exhibit lower trust. However, there are few differences in trust among the two groups and none at a health system level as we hypothesized. Instead, we see that women out of the professional labor force exhibit lower trust in the vaccine delivery (averaged based on C19 and childhood vaccines) driven by a trust disparity in Agency where unemployed women are significantly less trusting. This suggests that unemployed women are less trusting in being asked for consent or their consent being respected by the health system. *By unemployed we mean women who don’t “engage in activities for which you are paid in cash or kind”.
62
D I F F E R E N C E S
I N
T R U S T
|
C A R E G I V E R
B O Y / G I R L
FINDING
K E N YA
Caregivers answering on behalf of boys have lower trust in the vaccine – but have similar trust in the health system as caregivers answering on behalf of girls.
Testing trust differences between caregivers answering on behalf of boys or girls
T O TA L T RU S T
Girl Boy
70 67
QUADRANTS
GIRL
BOY
DIFFERENCE
Health system promise
71
70
Not significant
Healthcare delivery
62
62
Not significant DISPARITY
Vaccine promise Vaccine delivery
76 71
70 69
Incl. Agency
Excl. Agency
n = 2068
n = 1602
6 points (p<0.01) Not significant on quadrant level
Benefit
90
87
p<0.05
Relevance
78
66
p<0.01
Safety
54
51
p<0.01
Adequacy of info
72
68
Delivery settings
78
73
p<0.01
INTERPRETATION
In Kenya, the HPV vaccine is only offered to girls and all campaigns target girls exclusively with a strong emphasis on cervical cancer prevention and is, therefore, expected that caregivers answering on behalf of girls have higher trust in the vaccine – especially the vaccine promise where caregivers answering on behalf of girls hold higher trust in Benefit and the Relevance of the HPV vaccine. 63
D I F F E R E N C E S
I N
T R U S T
|
C A R E G I V E R
B O Y / G I R L
FINDING
PAK I STAN
There is little difference in trust between caregivers answering on behalf of boys or girls— except for Benefit, where caregivers answering for girls are more trusting.
Testing trust differences between caregivers answering on behalf of boys or girls
Vaccine promise
69
67
2 points (p<0.01)
T O TA L T RU S T
Vaccine delivery
71
71
Not significant
n = 2068
n = 1602
Girl Boy
68 67
QUADRANTS
GIRL
BOY
DIFFERENCE
Health system promise
65
64
Not significant
Healthcare delivery
61
62
Not significant DISPARITY
Benefit
84
82
p<0.01
INTERPRETATION
With the vaccine yet to be introduced in Pakistan, we did not expect large differences across caregivers answering on behalf of girls versus boys. As expected, we see no differences on the system level and only minimal variation on the vaccine level (imputed value calculated based on COVID-19 and childhood vaccine scores). 64
D I F F E R E N C E S
I N
T R U S T
|
E D U C AT I O N
FINDING
K E N YA
People with no education have significant lower trust in the health system promise and the vaccine delivery than those with at least primary education.
Testing differences between respondents without education and with at least primary education QUADRANTS
NO EDU
MIN. PRIMARY
DIFFERENCE
DISPARITY
Autonomy
Health system promise
68
71
3 points (p<0.01)
Healthcare delivery
62
62
Not significant
Vaccine promise
72
74
Not significant
72
76 p<0.01
Fairness
73
78
50
64
DISPARITY
T O TA L T RU S T
No education Primary Secondary
67 70 69
Vaccine delivery
68
71
n = 830
n = 2840
3 points (p<0.05)
Agency
p<0.01
INTERPRETATION
We expected that people with a higher education would have higher trust as they through the education system, have contact with the official system and might also have more contact with the health system. While our hypothesis is confirmed partly in higher trust in health system promise and vaccine delivery, the differences are quite small. This is likely due to the group with minimum primary education being a very diverse group that includes many different levels of education. 65
D I F F E R E N C E S
I N
T R U S T
|
E D U C AT I O N
FINDING
K E N YA
Higher education doesn’t yield higher trust—instead people who have completed primary as the highest level of education is significantly more trusting than people with no or longer educations.
Testing differences between respondents without education, primary education and secondary education
T O TA L T RU S T
No education Primary Secondary
67 70 69
QUADRANTS
NO EDUCATION
SECONDARY
PRIMARY
Health system promise
68
+3 points (p<0.01)
71
0 point Not significant
71
Healthcare delivery
62
+1 points (p<0.01)
63
-1 point (p<0.01)
62
Vaccine promise
72
+4 points (p<0.01)
76
-3 point (p<0.01)
73
Vaccine delivery
68
+3 points (p<0.05)
71
-1 point Not significant
70
n = 830
n = 1286
n = 1554
INTERPRETATION
Based on our qualitative findings, we expected people with low or no education to exhibit significantly lower trust than people with longer education. Interestingly, the quantitative results suggest that people who have completed primary education are the most trusted – in both the system and the vaccine. 66
D I F F E R E N C E S
I N
T R U S T
|
E D U C AT I O N
FINDING
PAK I STAN
People with no education have significantly lower trust in the health system delivery and vaccine delivery – driven primarily by low trust in the dimensions access, affordability and agency
Testing differences between respondents without education and with at least primary education
T O TA L T RU S T
No education Primary Secondary
66 67 69
QUADRANTS
Health system promise
NO EDU
64
MIN. PRIMARY
64
DIFFERENCE
Not significant DISPARITY
Healthcare delivery
59
62
3 points (p<0.01)
Vaccine promise
67
68
Not significant
Access
52
61 p<0.01
Affordability
40
49
62
67
DISPARITY
Vaccine delivery
69
72
n = 1011
n = 2723
3 points (p<0.01)
Agency
p<0.01
INTERPRETATION
As in Kenya, we expected people with a higher education to be more trusting as they through the education system have been in contact with the official system in some capacity. Our hypothesis is confirmed partly in healthcare delivery driven by discrepancies in Access and Affordability and in vaccine delivery driven by differences in the Agency. However, the differences are quite small, likely due to the group with minimum primary education being a very diverse group that includes many different levels of education.
67
D I F F E R E N C E S
I N
T R U S T
|
E D U C AT I O N
FINDING
PAK I STAN
People with a secondary education trust the vaccine and the health system delivery significantly more than other groups with shorter or no education.
Testing differences between respondents without education, primary education and secondary education
T O TA L T RU S T
No education Primary Secondary
66 67 69
QUADRANTS
NO EDUCATION
SECONDARY
PRIMARY
Health system promise
64
0 points Not significant
64
+1 point (p<0.05)
65
Healthcare delivery
59
+2 points (p<0.01)
61
+2 point (p<0.01)
63
Vaccine promise
67
+1 point Not significant
68
+1 point (p<0.05)
69
Vaccine delivery
69
+1 point Not significant
70
+3 point (p<0.01)
73
n = 1011
n = 1252
n = 1471
INTERPRETATION
Following our expectation that higher education yields higher trust, we see that people with a minimum of secondary education are more trusting than people with shorter or no education. While the differences in trust are significant, they are still quite small indicating that while trust differs across education levels, trust in the health system or the vaccine level isn’t driven by trust.
68
D I F F E R E N C E S
I N
T R U S T
|
P O V E R T Y
L I N E
FINDING
K E N YA
People above and below the poverty line1 trust similarly. Only trust in vaccine promise is slightly but significantly higher among people below the poverty line
Testing differences between respondents above and below the poverty line1
T O TA L T RU S T
Above Below
69 69
QUADRANTS
⍏
⍖
ABOVE
BELOW
Health system promise
70
0 points Not significant
70
Healthcare delivery
62
0 points Not significant
62 DISPARITY
⍏
⍖
Vaccine promise
73
2 points (p<0.02)
75
Safety
52
55
p<0.05
Vaccine delivery
70
1 point Not significant
71
Agency
64
53
p<0.01
Delivery setting
75
79
p<0.05
n = 2710
n = 960
INTERPRETATION
In Kenya, we observed no stark differences between respondents above and below the poverty line, contrary to expectations. The only significant— but slight—difference is trust in the vaccine promise, which is higher for respondents below the poverty line. At the dimension level, this seems to be driven by lower trust in safety, although both groups’ low scores indicate worry about side effects and adverse events. Perceived agency in receiving vaccines differed most starkly among the two groups, with respondents above the poverty line scoring 11 points higher. 1) Poverty lines in Kenya defined as Ksh 3,947 and Ksh 7,193 per person per month for rural and urban areas respectively, as defined by the Kenya Bureau of Statistics (2021) in World Bank 2023: “Kenya Poverty and Equity Assessment 2023”;
69
D I F F E R E N C E S
I N
T R U S T
|
P O V E R T Y
L I N E
FINDING
PAK I STAN
People above and below the poverty line1 reported similar levels of trust overall, with the only significant difference being trust in healthcare delivery
Testing differences between respondents above and below the poverty line1
T O TA L T RU S T
Above Below
68 67
QUADRANTS
Health system promise
⍏
⍖
ABOVE
64
0 points Not significant
BELOW
64
Healthcare delivery
63
4 points (p<0.01)
59
Vaccine promise
68
0 points Not significant
68
Vaccine delivery
71
1 point Not significant
72
n = 2243
DISPARITY
⍏
⍖
Access
60
55
Affordability
50
40
p<0.01
n = 1491
INTERPRETATION
In Pakistan, people in both groups scored similarly across dimensions, contrary to our expectations. People above the poverty line reported higher trust in healthcare delivery, although both groups reported lowest trust in this quadrant. Looking at dimension-level scores, it appears that low trust in access and affordability are the main drivers, with the latter being very low for both groups. Even so, people below the poverty line scored 10 points lower than those above. 1) Poverty lines in Pakistan, the national poverty line is calculated as USD 3.65 per person per day (30.000 PKR per month) in World Bank (2023): “Poverty and Equity Brief Pakistan “
70
D I F F E R E N C E S
I N
T R U S T
|
L A N G U A G E
FINDING
K E N YA
People answering the survey in a nondominant language have lower trust in the health system – but are equally trusting in vaccines as people answering in a dominant language
Testing differences between respondents answering survey in English & Kiswahili or other* language
T O TA L T RU S T
English / Kiswahili Other
69 67
QUADRANTS
D
*
ENGLISH /KISWAHILI
Health system promise
71
Healthcare delivery
62
Vaccine promise Vaccine delivery
5 points (p<0.01)
OTHER
66
2 points (p<0.01)
60
72
2 points Not significant
74
70
0 points Not significant
70
n = 2854
DISPARITY
D
*
Priority alignment
79
73 p<0.01
Autonomy
77
70
Access
58
51
Affordability
49
41
Agency
63
53
p<0.01
p<0.01
n = 812
INTERPRETATION
Using language as a proxy for proximity to power at a national scale, we expected that people answering in a non-dominate language (not English or Kiswahili) to be less trusting than dominant language speakers as they are further away from power in Kenya and have a higher likelihood of feeling politically marginalized or excluded from e.g., health campaigns. As hypothesized, people answering in a non-dominant language proved to have lower trust in, especially the health system, suggesting that people further away from power are less trusting in the health system promise and healthcare delivery. *Languages included in other: Kikamba, Kikuyu, Kisii, Luhya Lou, Masssai, Nadi, Somali, Turkana & Other
71
D I F F E R E N C E S
I N
T R U S T
|
L A N G U A G E
FINDING
PAK I STAN
People answering the survey in another language than Urdu are significanly less trusting than people answering the survey in Urdu across all trust quadrants
Testing differences between respondents answering in Urdu or other language
Vaccine promise
T O TA L T RU S T
Vaccine delivery
Urdu Other
68 65
QUADRANTS
U
URDU
*
OTHER
DIFFERENCE
DISPARITY
U
*
Priority alignment
69
65
Health system promise
65
63
-2 points
Healthcare delivery
62
60
-2 points
69
65
-4 points (p<0.01)
Relevance
63
57
72
69
-3 points
Delivery settings
80
76
n = 3027
n = 706
(p<0.05)
(p<0.01)
(p<0.01)
p<0.01
Fairness
61
50
Confidentiality
85
82
Affordability
47
44
Benefit
84
80
p<0.01
p<0.01
p<0.01
INTERPRETATION
Using language as a proxy for proximity to power at a national scale, we expected that people not answering in Urdu to be less trusting than Urdu speakers as they are further away from the centers of power in Pakistan and have a higher likelihood of feeling politically marginalized or excluded from e.g., health campaigns. As hypothesized, people who didn’t answer the survey in Urdu proved to have lower trust in both the health system and vaccines, suggesting that people further away from power are less trusting. *Languages included in other: Balochi, Brahvi, Hindko, Kashmiri, Punjabi, Pushto, Sindi & Other
72
D I F F E R E N C E S
FINDING
The North Eastern region stands out among the regions as having lower trust – especially in the vaccine
North Eastern Nyanza Rift Valley Western
R E G I O N S
0,66
0,75 0,59
0,69 0,71 0,69
0,8
0,4
0,2
0,2
0,0
System x Process 0,66 0,63
0,59 0,64 0,59 0,60
Intervention x Promise Intervention x Process
1,0 0,64 0,60
0,8
0,4
0,2
0,2
0,0
0,0
0,73 0,69
0,72 0,70 0,71 0,70
0,6
0,4
0,76 0,74 0,78
0,69 0,47
0,0
System x Promise
1,0
0,74 0,75 0,73
0,6
0,4
73 70 66 70 57 69 70 68
Nairobi
0,75 0,72
0,6
0,6
Eastern
|
1,0
0,8
0,8
Coast
T R U S T
1,0
T O TA L T RU S T
Central
I N
K E N YA
0,67
0,38
Central n = 461
Eastern n = 688
North Eastern n = 119
Rift Valley n = 869
Coast n = 352
Nairobi n = 369
Nyanza n = 514
Western n = 298
Total n = 3670
INTERPRETATION
Kenya's’ Northeastern region is experiencing high levels of conflict stemming from ethnic clashes, increasing drought and food insecurity and military operations along the border to Somalia - insecurity that are impeding healthcare and fruitful vaccination campaigns, and most likely result in significant lower trust compared to other more stable and less deprived regions.
73
D I F F E R E N C E S
I N
T R U S T
|
R E G I O N S
|
N O R T H
E A S T E R N
R E G I O N
FINDING
K E N YA
At the health system, the North Eastern region have particularly low trust score on Autonomy, Priority alignment, and Compassion relative to other regions
Testing health system trust differences between North Eastern and rest of Kenyan regions
T O TA L T RU S T
North Eastern Rest
57 69
HEALTH SYSTEM DIMENSIONS
NE
REST AVG
DIFFERENCE
P-VALUE
Autonomy
61
76
-15 points
<0.01
Priority alignment
54
78
-24 points
<0.01
Capability
51
52
-1 point
Not significant
Fairness
70
77
-7 point
<0.05
Confidentiality
77
83
-6 points
<0.05
Compassion
63
74
-11 points
<0.01
Competence
51
51
0 points
Not significant
Access
53
57
-4 points
Not significant
Affordability
53
47
6 points
<0.01
n = 119
n = 3670
INTERPRETATION
The North Eastern region in Kenya is poor and economically marginalized and local clans fight over the power in the region. Combined, these factors result in shifting power dynamics and experienced distance to the government power. We expected this to result in lower trust health system, and the quantitative analysis confirmed our expectations. This result suggests that distance to government power negatively impacts trust in the system. 74
D I F F E R E N C E S
I N
T R U S T
|
R E G I O N S
|
N O R T H
E A S T E R N
R E G I O N
FINDING
K E N YA
At the vaccine level, North Eastern region has significantly lower trust in the Benefit and Relevance of vaccines, as well as Adequacy of info and Delivery settings
Testing vaccine trust differences between North Eastern and rest of Kenyan regions VACCINE DIMENSIONS
Rest
57 69
REST AVG
DIFFERENCE
P-VALUE
Benefit
39
89
-50 points
<0.01
Relevance
52
73
-21 points
<0.01
Safety
50
53
-3 points
Not significant
Adequacy of info
56
71
-15 points
<0.01
Delivery setting
39
77
-38 points
<0.01
Agency
83
61
22 points
<0.01
n = 119
n = 3670
T O TA L T RU S T
North Eastern
NE
INTERPRETATION
Following the situation in the Northern Region with high insecurity and disrupted health campaigns, we expected trust in vaccines to be lower in this region compared to other regions, and the results confirmed our expectations. People are significantly less trusting in the Benefit of the HPV vaccine and the Delivery Setting – corresponding well with the volatile security situation in the region and the disrupted and often government-led HPV campaigns. 75
D I F F E R E N C E S
I N
T R U S T
|
U R B A N / R U R U A L
FINDING
K E N YA
Rural areas have significantly lower trust in the health system, while urban areas have significantly lower trust in the vaccines.
Testing trust differences between rural and urban areas*
T O TA L T RU S T
Urban Rural
69 69
QUADRANTS
RURAL
URBAN
OVERALL DIFFERENCE
Health system promise
69
71
2 points (p<0.01)
Healthcare delivery
61
63
2 points (p<0.05)
Vaccine promise
76
73
3 points (p<0.01)
Vaccine delivery
72
69
3 points (p<0.01)
n = 1125
n = 2545
Rural respondents have lower trust in the health system promise
Rural respondents have lower trust in healthcare delivery
Urban respondents have lower trust in the vaccine promise
Urban respondents have lower trust in the vaccine delivery
INTERPRETATION
Following the hypothesis that distances to power both in terms of actual distance, ethical ties, and economic prosperity negatively impact trust in the health system, the results confirm our expectation. Interestingly trust in the vaccine is higher in rural areas. However, the trust differences across urban and rural areas are quite small which suggests that urban/rural isn’t a strong driver of differences in trust.
76
D I F F E R E N C E S
FINDING
Across regions, Balochistan and Sindh have significantly lower trust than the rest of the country, especially in the vaccine promise and delivery. T O TA L T RU S T
Azad Jammu & Kashmir Balochistan Gilgit Baltistan ICT Khyber Pakhtunkhwa Punjab Sindh
I N
T R U S T
|
R E G I O N S
PAK I STAN
72 62 70 71 69 69 64
1,0
1,0 0,8 0,6
0,67
0,66 0,62 0,61 0,65 0,66 0,64
0,8
0,4
0,2
0,2 System x Promise System x Process
1,0 0,8 0,6
0,59 0,57
0,64 0,63 0,64 0,62 0,60
0,63
0,6
0,4
0,0
0,79
0,0
1,0 0,8
0,75 0,75 0,73
0,69
0,62
Intervention x Promise Intervention x Process 0,79
0,66
0,76 0,75 0,71 0,72
0,67
0,6
0,4
0,4
0,2
0,2
0,0
0,0
Azad Jammu & Kashmir n = 153
Gilgit Baltistan n = 156
Khyber Pakhtunkhwa n = 417
Balochistan n = 178
ICT n = 155
Punjab n = 1697
Sindh n = 978 Total n = 3734
INTERPRETATION
In Pakistan, we expected that poorer or politically marginalized regions with less influence on national politics would be less trusting in the health system and in the vaccines introduced and rolled out by the system. As expected, Balochistan and Sindh proved to be the least trusting regions, scoring lower on the health system level and at a vaccine level compared to others. Both Sindh and Balochistan are among the poorest regions in the country and host the largest numbers of e.g., Afghan refugees and internally displaced people. In addition, both regions especially Balochistan experience political marginalization. 77
D I F F E R E N C E S
I N
T R U S T
|
R E G I O N S
|
B A L O C H I S TA N
FINDING
PAK I STAN
At a health system level, Balochistan have particular low trust in Fairness and Affordability, but are at the same time more trusting on Priority Alignment compared to other regions
Testing health system trust differences between Balochistan and rest of Pakistani regions
T O TA L T RU S T
Balochistan Rest
62 68
HEALTH SYSTEM DIMENSIONS
BA
REST AVG
DIFFERENCE
P-VALUE
Autonomy
74
76
-2 points
Not significant
Priority alignment
71
66
5 points
<0.05
Capability
56
56
0 points
Not significant
Fairness
41
60
-19 points
<0.01
Confidentiality
76
84
-8 points
<0.01
Compassion
66
66
0 points
Not significant
Competence
51
51
0 points
Not significant
Access
53
59
-6 points
<0.01
Affordability
37
47
-10 points
<0.01
n = 178
n = 3734
INTERPRETATION
In Balochistan, we expected trust scores to be lower than the rest of the country, especially in the health system promise and healthcare delivery due to poverty, discrimination and political marginalization. As expected, Balochistan are less trusting especially in Fairness and Affordability.
78
D I F F E R E N C E S
I N
T R U S T
|
R E G I O N S
|
B A L O C H I S TA N
FINDING
PAK I STAN
At the vaccine level, Balochistan has lower trust in especially the Benefit and Relevance of the vaccine (avg. of childhood & C19), as well as the Delivery settings
Testing vaccine trust differences between Balochistan and rest of Pakistani regions VACCINE DIMENSIONS
Rest
62 68
REST AVG
DIFFERENCE
P-VALUE
Benefit
76
83
- 6 points
<0.01
Relevance
56
62
- 6 points
<0.01
Safety
56
59
- 3 points
<0.01
Adequacy of info
70
73
- 3 points
Not significant
Delivery setting
73
79
- 6 points
<0.01
Agency
64
66
- 2 points
Not significant
n = 178
n = 3734
T O TA L T RU S T
Balochistan
BA
INTERPRETATION
Balochistan has one of the lowest vaccine coverage rates in Pakistan, and we expected trust at the vaccine level to be lower than other regions. We found that people in Balochistan are less trusting especially in the vaccine promise (imputed based on C19 and childhood vaccines).
79
D I F F E R E N C E S
I N
T R U S T
|
R E G I O N S
|
S I N D H
FINDING
PAK I STAN
At the health system level, Sindh has a signficant lower trust score on Fairness in particular, as well as Confidentiality
Testing health system trust differences between Sindh and rest of Pakistani regions
T O TA L T RU S T
Sindh Rest
64 69
HEALTH SYSTEM DIMENSIONS
SI
REST AVG
DIFFERENCE
P-VALUE
Autonomy
72
77
-5 points
<0.01
Priority alignment
64
67
-3 points
<0.01
Capability
58
56
-2 points
<0.01
Fairness
53
61
-8 points
<0.01
Confidentiality
80
86
-6 points
<0.01
Compassion
63
68
-5 points
<0.01
Competence
51
51
0 points
Not significant
Access
57
59
-2 points
Not significant
Affordability
48
46
2 points
Not significant
n = 978
n = 3734
INTERPRETATION
The trust differences in Sindh compared to other regions are less pronounced than for Balochistan but still significant. At a health system level , Sindh is especially less trusting on Fairness which align with our expectations for a poorer and more politically marginalized region. While we see no significant differences on Affordability or Access as expected, Sindh does score lower on Confidentiality and Compassion which indicate a general lower trust in healthcare providers. 80
D I F F E R E N C E S
I N
T R U S T
|
R E G I O N S
|
S I N D H
FINDING
PAK I STAN
At the vaccine level, Sindh has lower trust all dimensions – especially on Benefit and Relevance, as well as Adequacy of info and Delivery settings compared to other regions
Testing vaccine trust differences between Sindh and rest of Pakistani regions VACCINE DIMENSIONS
Rest
64 69
REST AVG
DIFFERENCE
P-VALUE
Benefit
77
85
-8 points
<0.01
Relevance
53
65
-12 points
<0.01
Safety
57
60
-3 points
<0.01
Adequacy of info
63
75
-12 points
<0.01
Delivery setting
74
81
-7 points
<0.01
Agency
64
66
-2 points
<0.05
n = 978
n= 3734
T O TA L T RU S T
Sindh
SI
INTERPRETATION
Following the hypothesis that distances to power both in terms of actual distance, ethical ties, and economic prosperity, negatively impact trust at the health system level, the results confirm our expectations. However, the trust differences across urban and rural areas are quite small which suggests that urban/rural isn't a strong driver of differences in trust. 81
FINDING
PAK I STAN
Rural areas trust healthcare delivery less than uban areas, while urban areas trust the vaccine prpomise less.
Testing trust differences between rural and urban areas:
T O TA L T RU S T
Sindh Rest
64 69
QUADRANTS
RURAL
URBAN
OVERALL DIFFERENCE
Health system promise
65
64
Not significant
Healthcare delivery
60
63
3 points (p<0.01)
Vaccine promise
69
67
2 points (p<0.01)
Vaccine delivery
70
72
Not significant
n = 1820
n = 1914
Rural respondents have lower trust in healthcare delivery
Urban respondents have lower trust in the vaccine promise
INTERPRETATION
Following the hypothesis that distances to power both in terms of actual distance, ethical ties and economic prosperity, negatively impacts trust at the health system level , the results confirms our expectations. However, the trust differences across urban and rural areas are quite small which suggest that urban/rural isn’t a strong driver of differences in trust. *In Pakistan, urban is defined as cities with 100.000– 1 million or inhabitants, where rural is defined as villages with 5000 inhabitants or less
82
D I F F E R E N C E S
I N
T R U S T
|
V U L N E R A B I L I T Y
FINDING
K E N YA
There are no clear differences in trust when comparing the four vulnerability segments from the Pathway vulnerability tool.
Testing differences between the four vulnerability segments*
T O TA L T RU S T
69 Less 70 More/Most 65 Least
QUADRANTS
LEAST VULNERABLE
Health system promise
71
- 1 points Not significant
70
-2 point Not significant
68
- 1 point Not significant
67
Healthcare delivery
62
0 points Not significant
62
- 5 point Not significant
57
5 point Not significant
62
Vaccine promise
73
2 point p<0.01
75
- 7 point Not significant
68
1 point Not significant
69
Vaccine delivery
69
3 point p<0.05
72
- 7 point Not significant
65
- 3 point Not significant
62
n = 1325
LESS VULNERABLE
n = 1876
MORE VULNERABLE
n = 30
MOST VULNERABLE
n = 435
INTERPRETATION
Based on our ethnographic research, we expected that the most vulnerable populations groups (more and most vulnerable) would be less trusting especially in the promise and the process of the system driven by low trust in priority alignment and fairness at the promise level and low trust in access and affordability at the process level. However, there are no clear or significant differences in trust when we compare all four vulnerability segments. This might be explained by the big variation in population size, where the least vulnerable groups are strongly overrepresented. *The vulnerability segments are based on the Pathway Vulnerability Typing Tool
83
D I F F E R E N C E S
I N
T R U S T
|
V U L N E R A B I L I T Y
FINDING
K E N YA
The most vulnerable group is significantly less trusting compared to the least vulnerable – especially in the vaccine delivery
Testing differences between the least and the most vulnerability segments*
T O TA L T RU S T
69 Less 70 More/Most 65 Least
QUADRANTS
MOST VULNERABLE
LEAST VULNERABLE
Health system promise
71
Healthcare delivery
62
Vaccine promise
73
Vaccine delivery
69
- 4 points p<0.01
0 points Not significant
- 4 point p<0.05
-7 point p<0.01
n = 1325
67
62
69 DISPARITY
62
Agency
68
44
p<0.01
n = 435
INTERPRETATION
As we expected, the most vulnerable population is significantly less trusting than the least vulnerable group. While the trust disparity is evident in the health system as we expected, there are no differences in trust in healthcare delivery. The most vulnerable groups are significantly less trusting in vaccines especially the vaccine delivery which is driven by a lack of trust in Agency, suggesting that the most vulnerable people fear their consent won't be heard or respected. *The vulnerability segments are based on the Pathway Vulnerability Typing Tool
84
D I F F E R E N C E S
I N
T R U S T
|
Z E R O
D O S E
&
R E J E C T O R S
FINDING
K E N YA
HPV vaccine rejectors have significantly lower trust in the HPV vaccine - especially in the vaccine delivery
Testing differences between respondents who accept and those who reject the HPV vaccine QUADRANTS
Rejected Accepted
65 73
✓
REJECTED1
ACCEPTED1
Health system promise
69
3 points Not significant
72
Healthcare delivery
62
2 points Not significant
64
Vaccine promise T O TA L T RU S T
✕
Vaccine delivery
65
64 n = 127
5 points (p<0.01)
9 points (p<0.01)
80
73 n = 890
DISPARITY
✕
✓
Benefit
78
94
p<0.01
Relevance
68
84
p<0.01
Safety
42
58
p<0.01
Adequacy of info
63
74
p<0.01
Delivery settings
63
82
p<0.01
INTERPRETATION
In Kenya, caregivers rejecting childhood vaccines have lower trust in the health system and the vaccine. This indicates that caregivers rejecting childhood vaccines, generally, are less trusting in the health system, whereas parents rejecting the HPV vaccine showed similar trust levels in the system compared to HPV vaccine acceptors. 1) “Rejected” are defined as respondents who answered ”Yes” to being offered the vaccine, but “No” to having received it. “Accepted” are defined as respondents who answered “Yes” to being offered and receiving the vaccine.
85
D I F F E R E N C E S
I N
T R U S T
|
Z E R O
D O S E
&
R E J E C T O R S
FINDING
K E N YA
Childhood vaccine rejectors have significantly lower trust in the health system and in the vaccine promise and delivery
Testing differences between respondents who accept and those who reject childhood vaccines 2 QUADRANTS
63
Healthcare delivery
54
Rejected Accepted
60 72
Vaccine delivery
✓
REJECTED1
Health system promise
Vaccine promise T O TA L T RU S T
✕
65
61 n = 57
7 points (p<0.01)
8 points (p<0.01)
7 points (p<0.01)
14 points (p<0.01)
ACCEPTED1
70
62
82
75
DISPARITY
✕
✓
Benefit
77
96
p<0.01
Relevance
62
80
p<0.01
Safety
54
69
p<0.01
Adequacy of info
63
73
p<0.05
n = 3595
INTERPRETATION
In Kenya, caregivers rejecting childhood vaccines have lower trust in both the health system and in the vaccine. This indicates that caregivers rejecting childhood vaccines generally are less trusting in the health system, whereas parents rejecting the HPV vaccine showed similar trust level in the system compared to HPV vaccine accepters. 1) “Rejected” are defined as respondents who answered ”Yes” to being offered the vaccine, but “No” to having received it. “Accepted” are defined as respondents who answered “Yes” to being offered and receiving the vaccine. 2) Childhood vaccines is defined as measles, hepatitis B, yellow fever, DFP or other vaccines the respondent characterizes as childhood vaccines
86
D I F F E R E N C E S
I N
T R U S T
|
Z E R O
D O S E
&
R E J E C T O R S
FINDING
PAK I STAN
Childhood vaccine rejectors have significantly lower trust in the vaccine – especially the vaccine promise driven by lower trust in the benefit and relevance of childhood vaccines
Testing differences between respondents who accept and those who reject childhood vaccines 2
T O TA L T RU S T
Vaccine delivery
Rejected Accepted
63 68
QUADRANTS
✕
Health system promise
65
Healthcare delivery
61
Vaccine promise
✓
REJECTED1
62
67 n = 317
1 points Not significant
0 points Not significant
11 points (p<0.01)
5 points Not significant
ACCEPTED1
64
61
73
DISPARITY
✕
✓
Benefit
72
88
p<0.01
Relevance
55
65
p<0.01
Safety
60
65
p<0.01
72 n = 3405
INTERPRETATION
In Pakistan, both rejectors and accepters have lower trust in the health system, while caregivers rejecting childhood vaccines also have lower trust in the vaccines—especially the vaccine’s promise. This disparity is driven by significantly lower trust in the benefit and the relevance of childhood vaccines. 1) “Rejected” are defined as respondents who answered ”Yes” to being offered the vaccine, but “No” to having received it. “Accepted” are defined as respondents who answered “Yes” to being offered and receiving the vaccine. 2) Childhood vaccines is defined as measles, hepatitis B, yellow fever, DFP or other vaccines the respondent characterizes as childhood vaccines
87
D I F F E R E N C E S
I N
T R U S T
|
N U L L
F I N D I N G S
We have explored differences in trust across multiple variables with no distinct results or clear patterns INCOME
We hypothesized that high income groups would be more trusting but found no clear evidence: • In Kenya, the trust score in Affordability increased by 4%- points from lowest income group to highest income group. • In Pakistan, low-income groups had slightly lower trust in healthcare delivery driven by discrepancies on Access and Affordability.
M A R I TA L S TAT U S
When testing the differences in trust across marital status e.g., married, divorced etc., we found no clear differences in trust levels.
AGE
We hypothesized that younger respondents either would 1) would have higher trust in the vaccine because they themselves have been close to the target group for the HPV vaccine, or 2) have lower trust in the vaccine because they are more digital and as a result potentially more exposed to misinformation. We observe no significant patterns on a health system level, and a small significant difference in the vaccine promise.
NUMBER OF CHILDREN
EXPOSURE T H E O RY
We hypothesized that families with more children had more contact with health services and would have higher trust in the health system. We found no significant relationship between number of children and trust, when we calculated the total number of sons and daughters in the household.
We hypothesized that that women are more exposed to the healthcare system and that could explain their higher trust level. trust. In Kenya, women are more exposed to hospital providers, but not community providers. In Pakistan, women are less exposed to the healthcare system than men overall, disproving the hypothesis.
88
Methodology Sample composition Quantifying the Trust Framework Differences in trust
Trust and the effect on vaccine uptake HPV learnings
89
C H A P T E R
O V E R V I E W
In the following chapter, we test the effect of trust on vaccine uptake, how the different trust types interact and how trust shape women and marginalized groups CHAPTER OUTLINE
The effect of trust on vaccine uptake
We present the key argument – that trust drives vaccine uptake across vaccines and outline the marginal effect of trust
Key trust interactions
We outline how the four trust types interact with each other
S U M M A RY
Key learnings: Trust & Gender
Key learnings: Marginalized groups
We explore how the effect of trust on vaccine uptake differs across genders
We explore how trust influences vaccine uptake for marginalized groups – approximated by region and survey language
•
Trust drives vaccine uptake – when trust is high, so is the predicted likelihood of vaccine
•
Trust drives women to action before men when women have health decision power
•
For the most marginalized, the effect of trust on vaccine uptake is just as strong as for others
90
T R U S T
&
VA C C I N E
U P TA K E
|
K E N YA
Across vaccines, building trust pays off Observed uptake
Level of trust
Predicted uptake had trust been high1
HPV
63%
73%
C19
62%
75%
Childhood vaccines
98%
>99%
K E N YA
The trust dividend
**
Predicted probability of vaccination
Plot: Total trust’s effect on predicted likelihood of vaccination for HPV, COVID19, and childhood vaccines in Kenya
*)Childhood vaccination rates are higher from the onset due to childhood vaccines' long history within maternal and pediatric healthcare and the nature of the data sample that skews towards higher childhood vaccination rates . 1) Predicted uptake with total trust at 80 on average 91
T R U S T
&
VA C C I N E
U P TA K E
|
PA K I S TA N
Across vaccines, building trust pays off Observed uptake
Level of trust
Predicted uptake had trust been high1
C19
84%
95%
Childhood vaccines
91%
97%
PAK I STA N
The trust dividend
*
Predicted probability of vaccination
Plot: General trust’s effect on predicted likelihood of vaccination for HPV, COVID19, and childhood vaccines in Pakistan
*)Childhood vaccination rates are higher from the onset due to childhood vaccines' long history within maternal and pediatric healthcare and the nature of the data sample that skews towards higher childhood vaccination rates . 1) Predicted uptake with total trust at 80 on average 92
T R U S T
&
VA C C I N E
U P TA K E
|
K E N YA
The predicted likelihood for vaccine uptake in Kenya based on the total trust scores are as follows… PREDICTED
UPTAKE
Min., 1st quartile, median, 3rd quartile and max. value of the general trust score
1st quartile
Median
3rd quartile
Max.
HPV
22%
53%
64%
72%
83%
C19
17%
51%
64%
74%
86%
Childhood vaccines1,2
90%
98%
99%
>99%
>99%
1) Childhood vaccines is defined as measles, hepatitis B, yellow fever, DFP or other vaccines the respondent characterizes as childhood vaccines.
K E N YA
Min.
2) The high prevalence of childhood vaccine makes increased trust less impactful when driving vaccine uptake, because vaccine coverage is high from the onset (98% in Kenya and 92% in Pakistan based on our sample ). 93
T R U S T
&
VA C C I N E
U P TA K E
|
PA K I S TA N
The predicted likelihood for vaccine uptake in Kenya based on the total trust scores are as follows… PREDICTED
UPTAKE
Min., 1st quartile, median, 3rd quartile and max. value of the general trust score
1st quartile
Median
3rd quartile
Max.
C191
47%
79%
86%
91%
96%
Childhood vaccines2,3
76%
89%
92%
94%
96%
1) In Pakistan, trust played a smaller role in COVID19 vaccination that was mandated upon the population. 2) Childhood vaccines is defined as measles, hepatitis B, yellow fever, DFP or other vaccines the respondent characterizes as childhood vaccines.
PA K I S TA N
Min.
3) The high prevalence of childhood vaccine makes increased trust less impactful when driving vaccine uptake, because vaccine coverage is high from the onset (98% in Kenya and 92% in Pakistan based on our sample ). 94
T R U S T
&
VA C C I N E
U P TA K E
|
K E N YA
In Kenya, the trust quadrants’ average marginal effects on vaccine uptake are as follows… ALL M ARGINAL E FFE CT S K E N YA
SUPPRESSOR EFFECT
HPV
COVID-19
0%-pts
-19%-pts
Healthcare delivery
21%-pts
-16%-pts
3%-pts
Vaccine promise
29%-pts
60%-pts
6%-pts
Vaccine delivery
28%-pts
44%-pts
Health system promise
(Not significant)
Childhood vaccines1,2
-1%-pts
(Not significant)
2%-pts
We are observing a suppressor effect when it comes to the relationship between trust in the health system promise and C-19 vaccination in Kenya. This means the initially positive link between health system promise trust and C19 vaccination turns negative when accounting for other trust types. It implies that those trusting the health system promise also trust the vaccine, leaving the scenario of trusting the vaccine but not the health system promise to explain.
(Not significant)
The marginal effect explains how a change in the trust score from 0100 influences the likelihood of vaccination on average.3 1) Childhood vaccines is defined as measles, hepatitis B, yellow fever, DFP or other vaccines the respondent characterizes as childhood vaccines.
2) The high prevalence of childhood vaccine makes increased trust less impactful when driving vaccine uptake, because vaccine coverage is high from the onset (98% in Kenya and 92% in Pakistan based on our sample ).
3) Statistically, the marginal effect represents the change in the probability of the dependent variable (vaccine uptake) due to a one-unit in the independent variable (trust) – in our case when trust goes from 0-100 95
T R U S T
&
VA C C I N E
U P TA K E
|
PA K I S TA N
In Pakistan, the trust quadrants’ average marginal effects on vaccine uptake are as follows… ALL M ARGINAL E FFE CT S PAK I STAN
SUPPRESSOR EFFECT
COVID-191
Childhood vaccines2,3
Health system promise
-8%-pts
-3%-pts (Not significant)
Healthcare delivery
11%-pts
5%-pts
Vaccine promise
12%-pts
6%-pts
Vaccine delivery
9%-pts
We are observing a suppressor effect when it comes to the relationship between trust in the health system promise and C-19 vaccination in Pakistan. This means the initially positive link between health system promise trust and C19 vaccination turns negative when accounting for other trust types. It implies that those trusting the health system promise also trust the vaccine, leaving the scenario of trusting the vaccine but not the health system promise to explain.
1%-pts (Not significant)
The marginal effect explains how a change in the trust score from 0100 influences the likelihood of vaccination on average.4 1) In Pakistan, trust played a smaller role in COVID19 vaccination that was mandated upon the population. 2) Childhood vaccines is defined as measles, hepatitis B, yellow fever, DFP or other vaccines the respondent characterizes as childhood vaccines.
3) The high prevalence of childhood vaccine makes increased trust less impactful when driving vaccine uptake, because vaccine coverage is high from the onset (98% in Kenya and 92% in Pakistan based on our sample ).
4) Statistically, the marginal effect represents the change in the probability of the dependent variable (vaccine uptake) due to a one-unit in the independent variable (trust) – in our case when trust goes from 0-100 96
T R U S T
&
VA C C I N E
U P TA K E
|
K E N YA
Visually, the average marginal effects of the trust quadrants compare as follows… H P V VA C C I N E
C 1 9 VA C C I N E
C H I L D H O O D VA C C I N E S
-19%-pts
0%-pts
-1%-pts (Not significant)
(Not significant)
21%-pts
29%-pts
3%-pts
-16%-pts
60%-pts
6%-pts
2%-pts 28%-pts
Plot: The marginal effect of the four trust quadrants on HPV vaccine uptake
44%-pts
Plot: The marginal effect of the four trust quadrants on COVID-19 vaccine uptake
(Not significant)
Plot: The marginal effect of the four trust quadrants on childhood vaccine uptake 97
T R U S T
&
VA C C I N E
U P TA K E
|
PA K I S TA N
Visually, the average marginal effects of the trust quadrants compare as follows… C 1 9 VA C C I N E
C H I L D H O O D VA C C I N E S
-3%-pts
-8%-pts
(Not significant)
11%-pts
5%-pts
12%-pts
9%-pts
Plot: The marginal effect of the four trust quadrants on COVID-19 vaccine uptake
6%-pts
1%-pts (Not significant)
Plot: The marginal effect of the four trust quadrants on childhood vaccine uptake 98
T RU S T A N D T H E E F F E C T O N VA C C I N E U P TA K E
Key trust interactions
99
T R U S T
&
VA C C I N E
U P TA K E
|
T R U S T
I N T E R A C T I O N S
High trust in the vaccine promise helps establish resilient demand—also for the people with the lowest trust in vaccine delivery High trust in the vaccine promise can compensate for lower trust in the vaccine delivery
Plot: Predicted probability of HPV vaccination in Kenya for fixed levels of vaccine delivery trust, as vaccine promise trust increases H P V
—
K E N YA
47
%
Probability of HPV vaccination with vaccine promise at 80, and vaccine delivery at minimum
In Kenya, we observe a notable increase in HPV uptake for all levels of vaccine delivery trust as vaccine promise trust increases, including those with minimal trust in the vaccine delivery 47% probability of HPV
vaccination if trust in the vaccine promise is at 80, and trust in the vaccine delivery at minimum
100
T R U S T
&
VA C C I N E
U P TA K E
|
T R U S T
I N T E R A C T I O N S
High trust in the vaccine promise helps establish resilient demand—also for the people with the lowest trust in vaccine delivery High trust in the vaccine promise can compensate for lower trust in the vaccine delivery
Plot: Predicted probability of childhood vaccination in Pakistan for fixed levels of vaccine delivery trust, as vaccine promise trust increases C H I L D . V A C 1 — P A K I S T A N
98% probability of HPV
In Pakistan, high vaccine promise trust can also compensate for low trust in vaccine delivery, leading to high childhood vaccines coverage for all levels of vaccine delivery
vaccination if trust in the vaccine promise is at 80, and trust in the vaccine delivery at minimum
98
%
Probability of childhood vaccination with vaccine promise at 80, and vaccine delivery at minimum2
0.8
1) Childhood vaccines is defined as measles, hepatitis B, yellow fever, DFP or other vaccines the respondent characterizes as childhood vaccines 2) Coverage is already high in our sample (91%) producing high baseline vaccination rates
101
T R U S T
&
VA C C I N E
U P TA K E
|
T R U S T
I N T E R A C T I O N S
A lack of trust in the delivery of healthcare introduces a negative spillover to vaccine uptake—even when people do trust a specific vaccine Low trust in healthcare delivery partly outweighs the positive effect of trust in vaccine promise— making high trust in health delivery a critical lever to lift vaccine uptake In Kenya: For people with low trust in healthcare delivery1, building trust in the HPV vaccine has a smaller effect on uptake compared to the rest of the population
Plot: Predicted likelihood of HPV vaccination for lowest quartile of health delivery trust compared to rest as vaccine trust increases H P V
—
K E N YA
The difference in marginal effect of trust in the vaccine for those in lowest quartile of trust in health delivery compared to rest3
-19%-points difference in effect of trust in the HPV vaccine for those in lowest quartile of healthcare delivery trust compared to rest
Trust dividend for low trust in healthcare delivery
1) Lowest quartile of healthcare delivery 2) Childhood vaccines is defined as measles, hepatitis B, yellow fever, DFP or other vaccines the respondent characterizes as childhood vaccines 3) When trust in the vaccine increases from 0-100 and controlling for the other trust types
Trust dividend for medium to high trust in healthcare delivery
-19%-pts
Average difference in effect of increasing vaccine trust between low healthcare delivery trust1 and rest
102
T R U S T
&
VA C C I N E
U P TA K E
|
T R U S T
I N T E R A C T I O N S
A lack of trust in the delivery of healthcare introduces a negative spillover to vaccine uptake—even when people do trust a specific vaccine Low trust in healthcare delivery outweighs the positive effect of trust in vaccine promise—making high trust in health delivery a critical lever to lift vaccine uptake In Pakistan: For people with medium to high trust in healthcare delivery, building trust in childhood vaccines1 increases the already high uptake—but for those with low trust in healthcare delivery,1 we barely see an effect
Plot: Predicted likelihood of childhood vaccination for lowest quartile of health delivery trust compared to rest as vaccine trust increases C H I L D . V A C 2 — P A K I S T A N
Trust dividend for medium to high trust in healthcare delivery
No trust dividend for low trust in healthcare delivery, with slope remaining flat
-7%-points difference in effect of trust in the C19 vaccine for lowest quartile of healthcare delivery trust compared to rest
0.5
1) Childhood vaccines is defined as measles, hepatitis B, yellow fever, DFP or other vaccines the respondent characterizes as childhood vaccines 2) Lowest quartile of healthcare delivery 3) When trust in the vaccine increases from 0-100 and controlling for the other trust types
The difference in marginal effect of trust in the vaccine for those in lowest quartile of trust in health delivery compared to rest3
-7%-pts
Average difference in effect of increasing vaccine trust between low healthcare delivery trust1 and rest
103
T R U S T
&
VA C C I N E
U P TA K E
/
C O N T R O L
&
F I G H T
A N
E P I D E M I C
Kenya exemplifies how building trust in the vaccine delivery has a strong, positive trust dividend on uptake if combined with a moderate level of trust in the vaccine promise Plot: Predicted C19 vaccination in Kenya for fixed levels of vaccine promise trust, as vaccine delivery trust increases
K E N YA
In Kenya, trust in vaccine delivery and vaccine promise increases C19 uptake— combined, we observe that for vaccine promise, ‘a little trust goes a long way’ to obtain high coverage
70% predicted vaccination rate for median vaccine promise, and vaccine delivery at 80 58% predicted vaccination rate for lowest quartile of vaccine promise, and vaccine delivery at 80
Increasing trust in vaccine delivery increases likelihood of C19 vaccination for all levels of vaccine promise trust, but the effect is lower for those with minimal trust in the C19 vaccine promise—and not enough on its own to secure containment due to low baseline vaccination rates.
Predicted probability of C19-vaccination for different levels of vaccine promise trust, had vaccine delivery been high
Increase in uptake as vaccine promise goes from minimum to 1st quartile
19% predicted vaccination rate for minimum vaccine promise, and vaccine delivery at 80
Vaccine promise trust Predicted probability of C19-vaccination with vaccine delivery trust at 80
M I N I M U M
L O W E S T Q U A RT I L E
M E D I A N
19%
58%
70% 104
T R U S T
&
VA C C I N E
U P TA K E
|
T R U S T
I N T E R A C T I O N S
In Pakistan, combining trust in the vaccine delivery with a mandate resulted in high vaccine uptake Plot: Predicted C19 vaccination in Pakistan for fixed levels of vaccine promise trust, as vaccine delivery trust increases
92% predicted probability of C19 vaccination
87% predicted probability of C19 vaccination
PAK IS TA N
80% predicted probability of C19 vaccination 68% predicted probability of C19 vaccination
Vaccine promise trust Predicted probability of C19vaccination with vaccine delivery trust at minimum
In Pakistan, the C19 roll-out combining vaccine delivery efforts with a mandate to be vaccinated affects predicted uptake in two distinct ways… High baseline vaccination rates despite low levels of trust: For Pakistan, we observe high baseline vaccination rates for all irrespective of trust in the C19 vaccine promise and delivery, suggesting that force played a significant role in ensuring uptake Vaccine delivery trust has a strong effect for the least trusting in the C19 vaccine promise: In parallel, we observe that the effect of vaccine delivery trust is particularly strong for those with minimal trust in the vaccine promise—its benefit, efficacy and safety—most likely accelerated by the mandate
M I N I M U M
L O W E S T Q U A R T I L E
68%
80%
Vaccine promise trust Predicted probability of C19vaccination with vaccine delivery trust at 80
M I N I M U M
L O W E S T Q U A R T I L E
87%
92% 105
T RU S T A N D T H E E F F E C T O N VA C C I N E U P TA K E
Key learnings: Gender
106
T R U S T
&
V U L N E R A B L E
G R O U P S
|
W O M E N
In Kenya, any level of trust has a higher effect on vaccine uptake for women than men when women report to have health decision power—making trust a key instrument to lift women’s health Definition: Health decision power Respondents who have answered “I am in charge of child health decisions” to the question “Who in your household is most in charge of child health decisions, such as when and where to seek care when a child is sick?” are defined to hold health decision power.
Trust drives women to act before men when women have health decision power: Women will then accept a vaccine on substantially lower levels of trust in the vaccine compared to men K E N YA Plot: Predicted HPV vaccination for men and women caregivers overseeing healthcare decisions for their children in Kenya as total trust increases
70% likelihood of HPV vaccination
Women Trust score on 72
Men Trust score on 92
Women with health decision power:
72%
of women in Kenya identified themselves as main decisionmaker when it came to their child’s health (n = 2121)
A trust score difference of 20 points to achieve the same predicted vaccine uptake
1) The data sample in Kenya skews towards higher income groups. This might result in a higher share of women who report to have health decision power compared to the true population.
Women with health decision power have 70% likelihood of HPV vaccinating their adolescent with a general trust score on 72… … Men with health-decision power, however, need a general trust score on 92 to reach a 70% likelihood of HPV vaccinating their adolescents This effect persists across vaccines in Kenya, where women report to have high health decision power1 but not in Pakistan. 107
T R U S T
&
V U L N E R A B L E
G R O U P S
|
W O M E N
While trust can drive people to vaccinate, trust appears to play a smaller role for women’s vaccination decisions in Pakistan—even when women report to oversee children’s health Definition: Health decision power Respondents who have answered “I am in charge of child health decisions” to the question “Who in your household is most in charge of child health decisions, such as when and where to seek care when a child is sick?” are defined to hold health decision power. Women with health decision power:
37%
While trust is a strong lever for men’s health decision-making, its impact is less pronounced for women—likely stemming from entrenched patriarchal structures PAK I STAN Plot: Predicted childhood vaccination for men and women caregivers overseeing healthcare decisions for their children in Pakistan as total trust increases
With a predicted vaccination rate of 80% when trust is at minimum, the trust dividend for women is notably small
With a total trust score of 80, men’s predicted likelihood to vaccinate is 98%—4%-pts higher than women at 94%
of women in Pakistan identified themselves as main decisionmaker when it comes to their child’s health (n = 912)
1) The data sample in Kenya skews towards higher income groups. This might result in a higher share of women who report to have health decision power compared to the true population.
In Pakistan, the impact of trust appears to be less pronounced for women compared to Kenya. This might be a result of the Pakistani society where female health decision-makers often still rely on male relatives to, e.g., visit a health provider, and many women, therefore, de facto rely on men to execute health decisions – minimizing women’s decision power For the C19 vaccine, the effect of trust is also bigger for men in Pakistan compared to women 108
T R U S T
&
V U L N E R A B L E
G R O U P S
|
W O M E N
When women’s trust is at risk in Kenya, it is primarily driven by fear that their consent to a vaccine will be compromised—especially for low-income, unemployed women There are indications1 that the pattern of higher trust among women doesn’t hold when looking at the dimension of agency*, defined as trust in the process of informed consent
Unemployed women3 exhibit significant lower trust in vaccine delivery compared to employed women—driven by a lack of trust in the process of consent collection H P V
Subset: Below the poverty line
K E N YA
K E
HPV
C19
Trust in agency
61
88
Trust in agency
66
89
Trust in vaccine delivery unites three dimensions:2 A D E QUAC Y
O F
D E L I V E RY
S E T T I N G
EMPLOYED
General trust
70 67
The perceived adequacy of consent collection, incl. whether people trust they will be asked for their consent and whether this decision is respected 1) Difference between genders are insignificant (p>0.05), yet breaks observed pattern of women having higher trust than men 2) For an overview of all trust dimensions, see appendix 2
/100
/10
0
Trust in agency is critically low for women in Kenya with monthly incomes below the poverty line. H P V EMPLOYED
Trust in the vaccine delivery
72/100
Trust in agency
63/100
I N F O
AG E N C Y
UNEMPLOYED
n = 2178
n = 2178
67
/100
n = 766
52
/100
n = 766
72/100 n = 570
55/100 n = 570
K E N YA UNEMPLOYED
67
This may speak to country-specific contexts, with Kenya generally offering more possibility for women’s decision-making, and so, the lack of agency is felt more strongly.
/100
n = 275
46
/100
n = 275
3) Unemployed is defined as women who ”don’t engage in activities for which they are paid in cash or kind”. The definition builds on the World Bank’s definition and is adjusted to the LMIC context with input from the project’s gender advisors. https://databank.worldbank.org/metadataglossary/world-development-indicators/series/SL.IND.EMPL.ZS 4) Poverty lines in Kenya defined as Ksh 3,947 and Ksh 7,193 per person per month for rural and urban areas respectively, as defined by the Kenya Bureau of Statistics (2021) in World Bank 2023: “Kenya Poverty and Equity Assessment 2023”; For Pakistan, the national poverty line is calculated as USD 3.65 per person per day (30.000 PKR per month) in World Bank (2023): “Poverty and Equity Brief Pakistan “ 5) With Pakistan marked by caste stratification and patriarchal structures, women’s position in the social hierarchy is more vulnerable
109
T R U S T
&
V U L N E R A B L E
G R O U P S
|
W O M E N
In Pakistan, women’s trust is more at risk when it comes to the access and affordability of healthcare in general—with the biggest trust gaps observed for low-income, employed women There are indications1 that the pattern of higher trust among women doesn’t hold when looking at the dimension of affordability* of healthcare K E
Employed women3 trust healthcare delivery less than unemployed women, with employed women living below the poverty line emerging as an especially vulnerable group lacking trust in access and affordability of healthcare C 1 9
P A K I S T A N
P K
HPV
C19
C19
Trust in agency
61
88
66
Trust in agency
66
89
68
Trust in healthcare delivery unites five dimensions:2 C O N F I D E N T I A L I T Y C O M P A S S I O N C O M P E T E N C E
AC C E S S The perceived ease of accessing healthcare – incl. distance, time, navigation, language barriers, and availability of medical provisions
* A F F O R DA B I L I T Y The perceived ability to get healthcare when needed without having to forego or delay treatment due to cost 1) Difference between genders are insignificant (p>0.05), yet breaks observed pattern of women having higher trust than men 2) For an overview of all trust dimensions, see appendix 2
EMPLOYED
General trust
UNEMPLOYED
68 67 /100
/100
Subset: Below the poverty line Employed women under the poverty line are less trusting in the healthcare delivery – especially in affordability and access C 1 9
P A K I S T A N
EMPLOYED
Trust in healthcare delivery
56
Trust in affordability
44
Trust in access
73
/100
n = 226
/100
/100
n = 226
58
/100
n = 2251
46 66
/100
/100
n = 2251
57
/100
n = 570
32 50
/100
/100
n = 95
UNEMPLOYED
61
/100
n = 275
41 57
/100
/100
n = 904
For a large part of Pakistani society, women aren’t expected to work when married if it is financially feasible for the family. Therefore, it can be assumed that employed women under the poverty line are working out of necessity and live under more financially precarious conditions than unemployed women under the poverty line. This aligns with the results, where employed women under the poverty line are less trusting in healthcare delivery – especially in affordability and access.
3) Unemployed is defined as women who ”don’t engage in activities for which they are paid in cash or kind”. The definition builds on the World Bank’s definition and is adjusted to the LMIC context with input from the project’s gender advisors. https://databank.worldbank.org/metadataglossary/world-development-indicators/series/SL.IND.EMPL.ZS 4) Poverty lines in Kenya defined as Ksh 3,947 and Ksh 7,193 per person per month for rural and urban areas respectively, as defined by the Kenya Bureau of Statistics (2021) in World Bank 2023: “Kenya Poverty and Equity Assessment 2023”; For Pakistan, the national poverty line is calculated as USD 3.65 per person per day (30.000 PKR per month) in World Bank (2023): “Poverty and Equity Brief Pakistan “ 5) With Pakistan marked by caste stratification and patriarchal structures, women’s position in the social hierarchy is more vulnerable
110
T RU S T A N D T H E E F F E C T O N VA C C I N E U P TA K E
Key learnings: Marginalized groups 111
T R U S T
&
V U L N E R A B L E
G R O U P S
|
M A R G I N A L I Z E D
G R O U P S
To approximate marginalization, we have selected the variables survey language and geography
Definitions Survey language
Answering the survey in a nondominant language often signifies political and financial marginalization
Geography
Regional variation covers different political, economic, and security situations across a country
North Eastern Balochistan
K E N YA
Survey language: In Kenya, speaking a non-dominant language in conversation with strangers often indicates lower socioeconomic class and marginalization Speaking English or Kiswahili signals class in Kenya. When people prefer not or or isn’t able to answer survey in English/Kiswahili, it signals both financial and political marginalization and is closely tied to people’s socioeconomic class.
Geography: The North Eastern region is one of the poorest and most politically marginalized regions in Kenya SECURITY SITUATION The Northeastern region suffers from ethnic clashes and cattle fights exacerbated by severe droughts and food insecurity. ECONOMIC SITUATION Approx. 70% of people in the Northeastern region live below the poverty line and the region suffers from infrastructure deficit, including few roads and limited access to water.
PAKI S TA N
Survey language: Preferring not to or not being able to speak Urdu often signals lower income and some degree of political marginalization in Pakistan In Pakistan, Urdu is the dominant political language. While taught in schools across the country, some population groups don’t speak or prefer to speak in their local language, which often signals distance to the political and financial elites and, thereby, potential marginalization.
Geography: Balochistan is one of the most politically and financial marginalized regions in Pakistan SECURITY SITUATION For many years, Balochistan has faced significant security issues along the Afghan border, destabilizing everyday life for the population. ECONOMIC SITUATION More than 60% of people in Balochistan live below the poverty line and Balochistan has historically housed a significant number of Afghan refugees, who live in temporary dwellings with poor infrastructure and access to healthcare
112
T R U S T
&
V U L N E R A B L E
G R O U P S
|
M A R G I N A L I Z E D
G R O U P S
In Kenya, marginalized groups – both measured by language and geography - show increased vaccine uptake when trust increases, just like the rest of the population The likelihood of nondominant language speakers1 and people from the North Eastern region to be vaccinated increases significantly and comparably to the rest of the population when general trust2 increases.
K E N YA
Survey language G E N E R A L T RU S T H P V VAC C I N E
Geography
&
G E N E R A L T RU S T & C OV I D 1 9 VAC C I N E *
Comparable effect of trust on vaccine uptake
Non-dominant language n = 812
Kiswahili/English n = 2854
Comparable effect of trust on vaccine uptake
North Eastern n = 119
Rest of Kenya n = 3551
There is no significant difference between the effect of trust on vaccine uptake between dominant language speakers (English/Kiswahili) and non-dominant language speakers2 or between the North Eastern region and the rest of Kenya. This suggests that the effect of trust on HPV vaccination is comparable for marginalized groups and the rest of the population in Kenya 1) Non-dominant languages in Kenya: Kikuyu, Kikamba, Luhya, Somali, Kisii, Luo, Nadi, Turkana, Maasai 2) Trust, in this case, refers to a total trust score that compounds all four trust quadrants for given vaccine
*Due to the small sample size in each region, the results are indicative of a pattern, but the conclusions are not statistically robust 113
T R U S T
&
V U L N E R A B L E
G R O U P S
|
M A R G I N A L I Z E D
G R O U P S
Similarly, marginalized groups in Pakistan– both measured by language and geography - show increased vaccine uptake when trust increases, just like the rest of the population The likelihood of nonUrdu speakers1 and people from Balochistan to be vaccinated increases significantly and comparably to the rest of the population when general trust2 increases.
PAK IS TA N
Survey language
Geography
Comparable effect of trust on vaccine uptake
G E N E R A L T RU S T C H I L DVA C .
Non-Urdu n = 706
Urdu n = 3027
&
Comparable effect of trust effect of trust on vaccine uptake on vaccine uptake
G E N E R A L T RU S T & G E N E R A L T RU S T & C H I L DVA C . C H I L DVA C .
Balochistan n = 178
Rest of Kenya n = 3556
There is no significant difference between the effect of trust on vaccine uptake between Urdu and non-Urdu speakers1 or between Balochistan and the rest of Pakistan. This suggests that the effect of trust on childhood vaccination is comparable for marginalized groups and the rest of the population in Pakistan 1) Non-dominant languages in Pakistan: Punjabi, Sindhi, Pushto/Pashto, Balochi, Kashmiri, Hindko, Brahvi. 2) Trust, in this case, refers to a total trust score that compounds all four trust quadrants for given vaccine
*Due to the small sample size in each region, the results are indicative of a pattern, but the conclusions are not statistically robust 114
Methodology Sample composition Quantifying the Trust Framework Differences in trust Trust and the effect on vaccine uptake
HPV learnings 115
C H A P T E R
O V E R V I E W
In the following chapter, we outline perceptions pertaining to the HPV vaccine
CHAPTER OUTLINE K E N YA
Vaccine perception
Reasons for refusing the HPV vaccine
Reasons for accepting the HPV vaccine
PAK I STAN
Intermediaries and influencers
Preliminary learnings: HPV-vaccine in Pakistan
We examine the perceived benefits of the vaccine and the social and vaccine-specific beliefs that shape vaccine acceptance and refusal, as well as trusted influencers in the context of HPV across respondents, gender, and vulnerability.
We present the preliminary learnings on the HPV vaccine in Pakistan based on the small subset of the Pakistani.
116
H P V- S P E C I F I C
L E A R N I N G S
|
VA C C I N E
P E R C E P T I O N
The HPV vaccine offers a dual advantage in caregivers’ minds — it protects their child’s health, but also their community as a whole 74%
K E N YA
Single choice question In general, how important do you think it is for children to get the HPV vaccine to protect your community?
5% 6%
6% 7%
Not at all important
A little important
4%
Not at all important
5% 10% A little important
Answering for girls (n=2057)
FINDING
14% 15% 2% 3% Moderately important
Single Choice Question: How important is it for [Child] to get the HPV vaccine, also known as the ‘cervical cancer vaccine’ to protect her/his health, if available?
15%
69%
Very important
76% 60%
14% 14% Moderately important
Don’t know
1% 2% Very important
Don’t know
Answering for boys (n=1589)
The vast majority of caregivers answering on behalf of boys and girls report that the HPV vaccine is “Very important” to protect both their child’s health, but also their wider community As expected, caregivers answering on behalf of boys skew lightly towards less importance, especially when it comes to the importance of the HPV vaccine for their son’s health 117
H P V- S P E C I F I C
L E A R N I N G S
|
R E A S O N S
F O R
A C C E P T I N G
Perceived vaccine effectiveness — coupled with general vaccine acceptance — appears to drive uptake among caregivers whose daughters are vaccinated against HPV Single choice question: Do you agree with the following statement? 100
93%
90 80
K E N YA
94%
58%
50
HPV vaccine-specific beliefs: Respondents accepting the vaccine believe in the effectiveness of the HPV vaccine—with no notable difference in its protectiveness against HPV (92.7%) and cervical cancer (91.9%)
40 30 20 10 0
M O S T I M PA C T General vaccine acceptance: The most reported reason for accepting the HPV vaccine is that respondents in general believe that vaccines are important to get for their health (93.9%)
70%
70 60
93%
92%
L E A S T I M PA C T Everyone I know accepted the HPV vaccine for their children
The HPV vaccine will protect my daughter’s future
Pct. Answering Yes.
The HPV vaccine will prevent my daughter from getting cervical cancer
Somebody I trust told me it was important to vaccinate my daughter against HPV
The HPV vaccine prevents my daughter from getting HPV
I generally think vaccines are important to get
n = 890
Norm driven health-seeking behavior: While still impactful, fewer respondents report that everyone around them accepted the vaccine (57.8%)
Options: Yes, No, Don’t Know PROPRIETARY AND CONFIDENTIAL | 118 118
H P V- S P E C I F I C
L E A R N I N G S
|
R E A S O N S
F O R
R E F U S I N G
Caregivers who refused their daughters’ vaccination against HPV report concerns about side effects and a lack of information about the vaccine 100
Single choice question: Do you agree with the following statement?
90
M O S T I M PA C T
80
73%
Lacking information: The majority of respondents (73%) list a lack of information as a reason for not accepting the vaccine
70
K E N YA
60
50%
50
48% 49%
40 30
24% 24%
20
20%
10 0
27% 13%
6%
11%
14%
L E A S T I M PA C T
The HPV My Somebody I am I am I am My religion Everybody I need I want to I am Most vaccine daughter worried worried I trust told against is against I know more wait until worried family is not has a very me it was vaccines vaccines refused to that the information about the about side members effective low risk of minor side important in general let their HPV on the vaccine effects or close getting effects, not to daughters vaccine vaccine has been that will friends HPV such as vaccinate get the will around affect my opposed fever or a my HPV promote longer daughter’ the swollen daughter vaccine risky s future vaccine arm against behavior HPV
Pct. Answering Yes. Options: Yes, No, Don’t Know
Side effects: Respondents also report concerns around both short-term (50%) and long-term (49%) side effects of the HPV vaccine
n = 127
Religion: A minority of respondents cite their religion as a reason for not accepting the vaccine (6%) Norm driven behavior and opinions: Both opposing opinions from family and close friends (14%) as well as seeing surroundings refuse the vaccine (11%) play a minor role in the decision-making around the HPV vaccine PROPRIETARY AND CONFIDENTIAL | 119 119
H P V- S P E C I F I C
L E A R N I N G S
|
I N T E R M E D I A R I E S
&
I N F L U E N C E R S
Healthcare providers appear to hold the potential to play a pivotal role in increasing uptake among caregivers who initially refused the HPV vaccine 100 80
89%
Single choice question: Would you accept the HPV vaccine for [daughter] if it was recommended by…
M O S T I M PA C T Healthcare providers: The vast majority of caregivers report willingness to vaccinate against HPV if explicitly recommended by a healthcare provider (89%)
K E N YA
65% 60
54%
54%
53%
Family: 65% of caregivers who have refused the vaccine do report willingness to vaccinate if their family recommended it
37%
40 20 0
2% Your family?
Your friends?
Pct. Answering Yes. Options: Yes, No, Don’t Know
Their teacher?
Your Church?
A religious A healthcare figure (e.g., provider? a pastor, priest, sheikh, imam)?
Others?
n = 127
7/127
Caregivers who refused the vaccine will not accept the vaccine regardless of who recommended it
56/106
Caregivers are “Unlikely” to vaccinate their child (regardless of having been offered the vaccine) would accept the vaccine if a healthcare provider recommended it 120
H P V- S P E C I F I C
L E A R N I N G S
|
G E N D E R
There is little difference among female and male caregivers when it comes to their reasoning for accepting the HPV vaccine for their daughters Single choice question: Do you agree with the following statement?
93% 93%
100 90
92%
80
K E N YA
70 60 50
93% 91%
89%
94% 94%
For both women and men, general vaccine acceptance as well as believing in the effectiveness of the HPV vaccine remain the most reported reasons for having accepted the vaccine
71% 59%
M O S T I M PA C T
63% 51%
40 30 20 10 0
Everyone I know The HPV The HPV accepted the vaccine will vaccine will HPV vaccine for protect my prevent my their children daughter’s future daughter from getting cervical cancer
Women (n = 780) Pct. Answering Yes.
Options: Yes, No, Don’t Know
Men (n=110)
Somebody I trust told me it was important to vaccinate my daughter against HPV
The HPV vaccine prevents my daughter from getting HPV
I generally think vaccines are important to get
D I S PA R I T Y Light indications that social factors in the decision-making process—seeing people around you accepting the vaccine and having it recommended by a trusted individual—are slightly more prevalent for women than men (+8 %-points, +8 %-points) PROPRIETARY AND CONFIDENTIAL | 121 121
H P V- S P E C I F I C
L E A R N I N G S
|
G E N D E R
Similarly, men and women emphasize the same reasons for refusing the vaccine – both men and women report lacking information and concerns around side effects 100 90
Single choice question: Do you agree with the following statement?
80
M O S T I M PA C T 74%
70
K E N YA
60
50% 52%
50 40 30 20
24% 35% 22% 21%
10 0
The HPV vaccine is not effective
20% 17% 13% 13% 7%
49% 51% 43% 39% 27% 26% 11% 13%
Men (n=23)
13%
17%
0%
My I am Somebody I am My religion daughter worried I trust told against is against has a very about me it was vaccines vaccines low risk of minor side important in general getting effects, not to HPV such as vaccinate fever or a my swollen daughter arm against HPV
Women (n=104)
70%
Everybody I I am I need I want to I am Most family know worried that more wait until worried members refused to the HPV information the vaccine about side or close let their vaccine will on the has been effects friends daughters promote vaccine around that will opposed get the risky longer affect my the vaccine HPV behavior daughter’ vaccine s future
For both women and men, a lack of information about the HPV vaccine is the most prevalent reason for not accepting the HPV vaccine, followed by concern of short-term and long-term side effects D I S PA R I T Y Despite the small sample, more men than women believe their daughters to have very low risk of getting HPV(+14 %-points compared to women)—while more women than men worry about long-term side effects (+12 %-points compared to men)
Pct. Answering Yes. Options: Yes, No, Don’t Know
PROPRIETARY AND CONFIDENTIAL | 122 122
H P V- S P E C I F I C
L E A R N I N G S
|
G E N D E R
Women report more willingness to accept the vaccine if recommended by their surroundings and network 100 90 80
K E N YA
70 60
30
M O S T I M PA C T 74%
67% 59%
52%
57%
38% 30%
39%
35%
Healthcare providers remain the primary influencer whose endorsement would prompt most men and women to reconsider the HPV vaccine
55%
50 40
92%
Single choice question : Would you accept the HPV vaccine for [daughter] if it was recommended by…
43%
20
D I S PA R I T Y
10
3%
0
Your family? Your friends?
Women (n=104)
Their teacher?
Your Church?
Men (n=23)
Pct. Answering Yes. Options: Yes, No, Don’t Know
A religious A healthcare figure (e.g., a provider? pastor, priest, sheikh, imam)?
0%
Others?
While we observe disparity across all actor types, results indicate that teachers are especially divisive with 59% of women reporting a willingness to accept the vaccine if recommended by teachers, compared to only 35% of men
PROPRIETARY AND CONFIDENTIAL | 123 123
H P V- S P E C I F I C
L E A R N I N G S
|
V U L N E R A B I L I T Y
General vaccine acceptance and trusting the effectiveness of the HPV vaccine remain the most impactful factors in accepting the vaccine across all vulnerability segments Single choice question: Do you agree with the following statement? 100
92%
90
95% 89%
92% 93%
92%
86%
80 67%
K E N YA
70 60 50
61%
72%
94%
89%
95% 93% 94%
General vaccine acceptance continues to be the most reported factor across vulnerability segments, alongside confidence in the effectiveness of the HPV vaccine against both HPV and cervical cancer
68%
59%
51%
40 30 20 10 0
Everyone I know The HPV accepted the vaccine will HPV vaccine for protect my their children daughter’s future
Least (n=286) Pct. Answering Yes. Options: Yes, No, Don’t Know
The HPV vaccine will prevent my daughter from getting cervical cancer
Less (n=516)
Somebody I trust told me it was important to vaccinate my daughter against HPV
MoreMost (n=87)
M O S T I M PA C T
The HPV vaccine prevents my daughter from getting HPV
I generally think vaccines are important to get
D I S PA R I T Y Light indications that more vulnerable populations are driven slightly more by general vaccine acceptance (94%) than confidence in the HPV vaccine (89% HPV; 86% cervical cancer) when comparing responses across vulnerability segments PROPRIETARY AND CONFIDENTIAL | 124 124
H P V- S P E C I F I C
L E A R N I N G S
|
V U L N E R A B I L I T Y
Lack of information and concerns around side effects remain the most reported reasons for refusing the vaccine across vulnerability segments 100 90
Single choice question: Do you agree with the following statement?
80
83% 76%
M O S T I M PA C T
75%
68%
67%
70 51%
60
46%
K E N YA
50 40 30 20
52% 50% 51%
23% 29% 25% 24% 25% 19%
44%
20% 25% 19% 17% 13%
10 0
3% 0%
27%
9% 10%
41%
27% 25%
13% 8%
25% 15% 11%
0%
The HPV My I am Somebody I am My religion Everybody I am I need I want to I am Most family vaccine daughter worried I trust told against is against I know worried more wait until worried members is not has a very about me it was vaccines vaccines refused to that the information the \ about side or close \ effective low risk of minor side important in general let \ntheir HPV on the nvaccine effects \ nfriends getting effects, not to daughters vaccine \ vaccine has been nthat will opposed HPV such as vaccinate get the nwill around affect my the vaccine fever or a my HPV promote longer daugher’s swollen daughter vaccine risky future against arm behavior HPV
Least (n=59)
Less (n=59)
MoreMost (n=12)
Pct. Answering Yes.
Options: Yes, No, Don’t Know * It important to bear in mind that our sample is smaller and therefore more uncertain for the ”MostMore” vulnerable
segment
Caregivers across vulnerability segments report needing more information about the HPV vaccine as well as concerns around side effects*
D I S PA R I T Y Our sample of more or most vulnerable populations who have refused the vaccination of their daughter is small (n=12); however, in this group of people, concerns around side effects appear to play a larger role compared to lesser vulnerability segments PROPRIETARY AND CONFIDENTIAL | 125 125
H P V- S P E C I F I C
L E A R N I N G S
|
V U L N E R A B I L I T Y
Healthcare providers continue to be the influencer whose recommendation would make people reconsider taking the HPV vaccine – no matter the vulnerability segment 100
Single choice question: Would you accept the HPV vaccine for [daughter] if it was recommended by…
90 80
K E N YA
M O S T I M PA C T
83%
73%
70 60
100% 93%
58%
64%
58%
53%
51%
49%
48%
50
61%
Healthcare providers remain the most trusted influencer across vulnerability segments, despite the smaller, and more uncertain sample
55% 42%
40
27%
30
33%
33%
33%
20
0
D I S PA R I T Y
5%
10
0% Your family?
Your friends?
Least (n=59)
Their teacher?
Less (n=59)
Your Church?
A religious figure (e.g., a pastor, priest, sheikh, imam)?
A healthcare provider?
0%
Others?
Results suggest that the Less vulnerable are generally more willing to reconsider HPV vaccination based on recommendations from their surroundings and network
MoreMost (n=12)
Pct. Answering Yes. Options: Yes, No, Don’t Know 126
Preliminary learnings: HPV-vaccine in Pakistan 127
H P V- S P E C I F I C
L E A R N I N G S
|
PA K I S TA N
Prior to the introduction of the HPV vaccine, respondents across Pakistan have very low awareness about the Human Papilloma Virus, and in turn, the vaccine against it
PA K I STAN
AWA R E N E S S OF H P V
6%
of respondents in Pakistan have heard about the Human Papilloma Virus
240 / 3734
Measured by the question: Have you heard about the infection human papillomavirus, also known as HPV?
AWA R E N E S S O F T H E H P V VA C C I N E
5%
of respondents in Pakistan have heard about the HPV vaccine
181 / 3734
Measured by the question: Have you heard about the HPV vaccine, also known as the "cervical cancer vaccine”? 128
H P V- S P E C I F I C
L E A R N I N G S
|
PA K I S TA N
The majority agrees that vaccines that targets adolescent girls specifically are suspicious – indicating that the HPV vaccine will raise question in Pakistan 100
PA K I STAN
80
Single choice question: Please tell me if you do not at all agree, somewhat agree, or strongly agree: “Vaccines that are specifically made for adolescent girls are suspicious”
FINDING
Almost one-third of the respondents strongly agree that vaccines specifically targeting adolescent girls are suspicious
60 40 20 0
34% 20%
Not at all agree
28% 18%
Somewhat agree
Strongly agree
Don’t know
The majority (62%) agree that vaccines specifically for adolescent girls are suspicious – 28% strongly agree, and 34% somewhat agree. This suggests that the HPV vaccine will raise concerns if introduced only to girls in Pakistan.
N = 3715
PROPRIETARY AND CONFIDENTIAL | 129 129
H P V- S P E C I F I C
L E A R N I N G S
|
PA K I S TA N
Across regions, people are suspicious of vaccines for girls only; especially so in Baluchistan and Sindh, where three-quarters were skeptical 100% 90%
Single choice question: Please tell me if you do not at all agree, somewhat agree, or strongly agree: “Vaccines that are specifically made for adolescent girls are suspicious”
FINDING
80%
PA K I STAN
70% 60%
58%
50%
37% 37%
40% 30% 20% 10% 0%
23%
Azad Jammu & Kashmir
43% 36% 34%
26% 21% 18% 15%
21%
12% 7%
38%
31% 25%
13%
23% 20%
Not at all agree
Gilgit Baltistan
ICT
Somewhat agree
13%
9%
6% Balochistan
35%
31% 27% 21% 21%
Khyber Pakhtunkhwa
Strongly agree
Punjab
Sindh
Don’t know
Residents in Baluchistan and Sindh are notably more suspicious of vaccines specifically targeting adolescent girls compared to the rest of Pakistan In Baluchistan, 74% agree that vaccines specifically for adolescent girls are suspicious – 37% strongly agree, and 37% somewhat agree. In Sindh, 78% agree that vaccines specifically for adolescent girls are suspicious – 43% strongly agree, and 35% somewhat agree. This suggests that the HPV vaccine will particularly raise concerns in these regions if introduced only to girls. PROPRIETARY AND CONFIDENTIAL | 130 130
H P V- S P E C I F I C
L E A R N I N G S
|
PA K I S TA N
People are most likely to accept the HPV vaccine if recommended by family or healthcare providers – suggesting the importance of activating health providers in a future HPV vaccine rollout 100 90
Single choice question: Would you accept the HPV vaccine if it was recommended by…
FINDING
80
PA K I STAN
70 60 50 40
36%
30
18%
20
27%
36% 18%
10
1%
0
Your family?
Your friends?
Their teacher?
A religious A healthcare figure (e.g., provider pastor, (e.g., a priest, nurse, sheikh, doctor, lady imam)? health worker)?
Pct. Answering Yes. Options: Yes, No, Don’t Know
Others N = 3734
Even for influencers with the highest impact on the HPV vaccine decision – family and healthcare providers – only one-third of respondents are willing to accept the HPV vaccine if recommended 36% of respondents are likely to accept the HPV vaccine if recommended by either a family member or healthcare provider. Only 18% are willing to accept the vaccine if recommended by friends or religious figures. PROPRIETARY AND CONFIDENTIAL | 131 131
H P V- S P E C I F I C
L E A R N I N G S
|
PA K I S TA N
People are most likely to accept the HPV vaccine if recommended by healthcare providers but in some regions, people turn to family members and teachers – underscoring the importance of activating the broader social community in a future HPV roll out 70%
Single choice question: Would you accept the HPV vaccine if it was recommended by…
FINDING
63%
While people in many regions are most likely to accept the HPV vaccine if recommended by healthcare providers, they are outweighed by family members in multiple regions
60%
PA K I STAN
50% 40%
53%
51% 46% 40% 40% 40% 37% 36% 33%
37%
41%
39% 37% 37% 36%
38% 35% 32%
30%
28% 25% 19%
20%
24% 24% 21% 17%
16% 16% 15% 13%
9%
10% 0%
34% 35%
29% 28%
1%2%0%1%1%1%2%
Your family?
Your friends?
Their teacher?
Azad Jammu & Kashmir
Balochistan
Gilgit Baltistan
Khyber Pakhtunkhwa
Punjab
Sindh
Pct. Answering Yes. Options: Yes, No, Don’t Know
A religious figure? A healthcare (e.g., pastor, provider? (e.g., a priest, sheikh, nurse, doctor, lady imam) health worker)
ICT
Others
In several regions, family—and in some cases, the child’s teacher’s— recommendations outweigh that of healthcare professionals, namely in Baluchistan (40% vs 38%), ICT (37% vs 34%), and Sindh (36% vs 28%). This underscores the importance of vaccine advice from from trusted community members, especially in areas where trust in healthcare providers is low. PROPRIETARY AND CONFIDENTIAL | 132 132
Original strategies for the worlds of tomorrow
www.redassociates.com COPENHAGEN | Kronprinsessegade 20 | 1306 Copenhagen K | Denmark | +45 3333 7044 | cph@redassociates.com NEW YORK | 26 Broadway Suite 2505 | NY 10004 New York | USA | +1 212 483 8788 | nyc@redassociates.com PARIS | 198 rue de Rivoli | 75001 Paris France | +33 6 28 76 24 79| paris@redassociates.com